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Multiple Sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system 
(CNS) that disrupts the flow of information within the brain, and between the brain the body. MS 
is the most common progressive neurologic disease of young adults, affecting approximately 2.3 
million people worldwide. It is estimated that more than 700,000 individuals are affected by MS 
in United States. While MS has been studied for decades, the cause of it is still not definite and a 
fully effective treatment for MS is not yet available. 
Magnetic resonance imaging (MRI) has been used extensively in MS diagnosis and for monitoring 
disease. Clinical T1W, T2W and Fluid Attenuated Inversion Recovery (FLAIR) images are able 
to detect focal WM lesions with high accuracy and are used in MS diagnosis. However, standard 
clinical MRI lacks specificity to MS pathology and correlates only modestly with MS disability. 
Many studies have been devoted to the development and experimental validation of quantitative 
methods sensitive to myelin damage (hallmark of MS), primarily by means of multiexponential 
T2 imaging of water trapped between myelin layers, magnetization transfer (MT) and diffusion 
tensor imaging. These techniques have not gained traction in clinical practice, prompting searches 
for novel, more pathologically specific and efficient approaches. In this thesis, two novel MRI 
techniques developed in our lab, quantitative Gradient Recalled Echo (qGRE) and Multi-Angular-
Relaxometry of Tissue (SMART), were used to quantitatively study MS tissue damage.  
Our qGRE technique (which is an advanced version of GEPCI – gradient echo plural contrast 
imaging) is based on quantitative measurements of the transverse relaxation properties of the 
Gradient Recalled Echo (GRE) MRI signal. This quantitative qGRE approach allows estimation 
of tissue damage in MS lesions and normal appearing WM and GM. An innovative qGRE method 
of data analysis allows separation of tissue-cellular-specific (R2t* relaxation rate constant) from 
xiii 
 
Blood Oxygen Level Dependent (BOLD) contributions to the total GRE MRI signal decay rate 
constant (R2*). Since BOLD effect causes variations in MRI signal that occur with physiological 
state-dependent changes in blood flow and/or oxygen consumption, the R2t* values more 
specifically reflect the tissue-cellular component of R2*. The tissue-cellular-specific (R2t*) MRI 
relaxation parameter depends on the environment of water molecules (the main source of MRI 
signal): higher concentrations of proteins, lipids, and other constituents of biological tissue and 
cellular constituents (sources of MRI signal relaxation) leading to higher relaxation rate constants. 
Our results showed that R2t* can sensitively detect MS-related pathology in cortical NAGM, 
subcortical NAWM and WM lesions. The method demonstrated tissue damage patterns in the CNS 
of the MS cohort. Our data shed light on the interrelationships of damage throughout the brain and 
cervical spinal cord, while supporting the idea of MS as a global CNS disease. In addition, our 
data demonstrated that while spinal cord CSA is a reliable marker for changes in motor functions, 
the reduction in the  R2t* of GM and WM is a reliable indicator of cognitive dysfunction. 
The SMART technique is also based on a GRE MRI sequence (but with multiple flip angles) and 
a model of GRE signal that accounts for cross-relaxation effects between “free” and “bound” water 
proton pools. Importantly, no MT pulses are used in SMART approach, thus overcoming high RF 
energy deposition associated with existing qMT approaches for evaluation of tissue 
macromolecular content. From a single protocol this technique can generate quantitative 
macromolecular proton fraction (MPF) images along with naturally co-registered quantitative 
images of longitudinal (R1=1/T1) and transverse (R2*=1/T2*) signal relaxation rate constants, and 
spin density. The SMART technique allows quantitative assessments of central nervous system 
(CNS) simultaneously using several tissue contrasts. Our results showed that the SMART metrics 
can distinguish progressive MS from relapsing-remitting MS (RRMS) and correlate with clinical 
xiv 
 
assessments. Without applying either MT or 180° radiofrequency pulses, SMART MRI generates 
high resolution quantitative images with various contrasts, and is safe for high-field MRI, making 













Chapter 1: Introduction 
1.1 Nuclear Magnetic Resonance Imaging 
Nuclear magnetic resonance imaging, or magnetic resonance imaging (MRI), is a noninvasive 
medical imaging modality widely used to form images of the anatomy, pathology and 
physiological process of the body. MRI relies on the spinning motion of magnetic resonance active 
nuclei. Given the large magnetic moment of 1H nuclei and its abundance inside the body, clinical 
MRI techniques focus on the hydrogen nucleus. Classical MRI textbooks have a more 
comprehensive description of this section [1, 2]. 
1.1.1 Nuclear spins 
In quantum mechanics, spin is an intrinsic property of atomic and subatomic particles. In nuclei 
that have an even mass number (with equal numbers of neutrons and protons), such as 12C and 16O, 
half spin is in one direction and half in the opposite direction, resulting in no net spins. For nuclei 
with odd mass numbers, such as 1H and 13C, spin in each directions are not cancelling out, resulting 
in net spin or angular momentum. These nuclei are referred as magnetic resonance active nuclei. 
The angular momentum S of any atomic or subatomic system is determined by spin quantum 
number s.  





  ,                                         (1.1) 
where h represents the Planck’s constant.                                                                           
The angular momentum of S along any direction is defined as: 




S s s s s s s

      ,                                (1.2) 
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Thus, a given particle has 2s+1 individual spin states in different directions.  
Magnetic moment describes how a small magnetic dipole interacts with an external magnetic field: 
                                                           0E B   ,                                                      (1.3) 
where E is the magnetic energy of a particle, and B0 is external magnetic field. µ is the intrinsic 
magnetic moment, which is defined as the product of the gyromagnetic ratio  the spin angular 
momentum S. 
The spin quantum number of a proton is 1/2. This means a proton has two possible spin states: 1/2 
(spin up) and -1/2 (spin down). In the absence of an external magnetic field, the magnetic moments 
of protons are randomly orientated. When placed in a static external magnetic field, there are only 
two spin states: parallel to the field and anti-parallel. The distribution of protons in these two states 
is determined by Boltzmann statistics as shown below: 
                            
0( ) exp( ) exp( )
( ) 2
h BPopulation anti parallel E




    ,                    (1.4) 
where k is the Boltzmann constant and T is the absolute temperature. Note the population ratio is 
nearly 1, at physiologic temperature and a magnetic field of 3T. Only a small excess on the order 
of 1 in a million spins can be expected to be found in the lower energy state. Fortunately, the 
concentration of protons in the biological tissue is high (approximately 55 mol/L), providing a 
sufficient magnetic resonance signal. 
For the convenience of describing signal generation process in MRI, nuclear spins are typically 
treated as the analogue of spins in classical physics. Notice that even the two energy states are 
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called parallel or anti-parallel, the magnetic moment of spins precesses around B0 instead of 
completely aligning with B0. The frequency of the precession is known as Larmor frequency: 
                                                             0 0B  .                                                         (1.5) 
0B is the strength of the magnetic field, and   is the gyromagnetic ratio. 
 
Figure 1.1  Illustration Of Spin Precession. Digital Image. MyMS.org, 
(https://myms.org/mri_physics.htm) 
 
1.1.2 Free induction decay 
Under external magnetic field 0B , nuclear spins are polarized, resulting a net magnetization along 
the 0B (z direction). Upon applying an radio frequency (RF) pulse of energy at the Larmor 
frequency of hydrogen, the net magnetization vector (NMV) moves out of alignment away from 
0B and precesses in the transverse plane (x,y plane). According to Faraday’s laws of induction, a 
voltage will be induced in a conductive loop if the magnetic flux through the loop varies in time. 
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In MRI scanner, a receiver coil in the transverse plane is used to collect the current induced by the 
precessing magnetization. The current will be amplified and processed to generate magnetic 
resonance (MR) signal. 
NMW will realign with 0B  by losing energy after the RF pulse is switched off. The process by 
which hydrogen nuclei lose energy gained from RF pulse is called relaxation.  
Relaxation causes two independent process: recovery of magnetization in the longitudinal 
direction (T1 recovery) and decay of magnetization in the transverse plane (T2* decay). T1 
recovery is also termed as spin lattice relaxation since it is caused by hydrogen nuclei lose its 
absorbed energy from RF pulse to the surrounding environment or lattice. After the RF pulse is 
switched off, the NMW in longitudinal direction ( zM ) changes as a function of time (t) in accord 
with the following equation: 
                                                0 1(1 exp( / ))zM M t T    .                                             (1.6) 
Meanwhile, the nuclear spins in the transverse plane will dephase due to magnetic field 
inhomogeneities, which is termed as T2* relaxation. The magnetic field inhomogeneities can be 
divided into macroscopic (including imperfect 0B  and field distortion due to air/tissue interfaces), 
causing reversible (with respect to 180˚ RF pulse) part of transverse signal decay, and microscopic 
(molecular level) causing irreversible part of transverse relaxation which is characterized by a T2 
relaxation time constant. T2 relaxation is also termed as spin-spin relaxation as it is caused by 
nuclei exchange energy with neighboring nuclei, precessing at slightly different frequencies due 
to microscopic inhomogeneous local magnetic field created by electron magnetic moment, 
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electron orbital current and nuclei themselves. After RF pulse is switched off, the NMW in 
transverse plane ( xyM ) decays as a function of time (t) in accord with the following equation: 
                                         0 2 0 0exp( / *) cos( )xyM M t T t       .                                 (1.7) 
Where ω0 is the Larmor frequency and φ0 is the initial phase. The magnitude of induced 
voltage/current in the receiver coil decreases as the magnitude of transverse magnetization 
decreases. This induction of reduced MR signal is called free induction decay (FID) signal. 
 
Figure 1.2 Illustration of Free Induction Decay, Digital image. Generating a Signal: RF Pulses 
and Echoes, 22 October 2010, https://link.springer.com/chapter/10.1007%2F978-1-84996-362-
6_4. 
 
1.1.3 Imaging Basics - Gradients and K-space 
The FID signal measures the whole object without distinguishing spins at different locations, 
which means FID signal could not be used to generate an image. To overcome this problem, a field 
gradient was applied to create a magnetic field that depends linearly on location. For instance, 
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applying a gradient xG  in the x-direction in addition to a uniform magnetic field 0B  (also in x-
direction), creates a spatially dependent field: 
                                                           0 xB B G x   .                                                   (1.8) 
Accordingly, the Larmor frequency also depends on the location:  
                                                   0 xB G x        .                                               (1.9) 
 In this case, spins of the imaging object will have different resonance frequencies at different 
locations, which is often termed as frequency encoding. Frequency encoding provides the one-
dimensional projection of the imaging object’s spin density along the field gradient. 
 
 
Figure 1.3 Illustration of frequency encoding. 
For two-dimensional imaging, a phase encoding gradient yG  is applied in the orthogonal direction 
to the frequency encoding gradient. Phase encoding gradient is applied after the RF pulse and 
before the frequency encoding gradient for a short period (typically on the order of milliseconds). 
During this time period, spins will accumulate certain amount of phase, depending on the location 
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in the Y direction. To obtain images of a three-dimensional object, an additional phase encoding 
gradient along Z direction is applied. The locations in the X direction are encoded by precession 
frequencies. The locations in the Y, Z directions are encoded by the accumulated phase. 
1.1.4 Gradient Recalled Echo (GRE) Sequence 
Since most imaging techniques in my projects are based on gradient echo sequence, more details 
are provided about this pulse sequence in this section. The following diagram shows a two-
dimensional version of gradient echo sequence. 
 
 
Figure 1.4 Pulse diagram of a gradient echo sequence. Digital image. How We Perform Myocardial 





During gradient echo experiment, a frequency selective RF pulse is applied along with a slice 
selective gradient, exciting spins in a targeting slice. In order to refocus the dephasing of spins 
caused by the slice-select gradient, a rewinding gradient will be applied in the slice direction. Next, 
a single step of phase encoding gradient is applied over certain time duration, so that spins along 
phase encode direction will accumulate spatially dependent phase. A pre-rewind gradient will then 
be applied over exactly half of the read-out duration in the frequency encoding direction. The 
readout gradient will then be turned on to refocus the spins in readout direction at the time of echo 
(TE), which is time difference between Signal receivers will be turned on to collect data during 
the readout gradient. The data points collected during on readout gradient will fill a single k-space 
line.  
The whole process will be repeated again with a different phase encoding gradient to fill another 
k-space line. The time delay between two excitation RF pulses is call time of repetition (TR). 
During one TR, one k-space line will be filled.   
Images of the object can be generated by inverse Fourier Transform. The relationship between k-




Figure 1.5 Relations between the time domain, frequency domain, k-space and real space. 
 
 
1.2 Multiple Sclerosis 
Multiple Sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system 
(CNS) that disrupts the flow of information within the brain, and between the brain the body. MS 
is the most common progressive neurologic disease of young adults, affecting approximately 2.3 
million people worldwide [3]. It is estimated that more than 700,000 individuals are affected by 
MS in United States [4]. While MS has been studied for decades, the cause of it is still not definite 
and a fully effective treatment for MS is yet available. 
International Advisory Committee on Clinical Trials of MS in 2013 has defined four basic MS 
disease courses: clinically isolated syndrome, primary progressive, secondary progressive and 
relapsing remitting. Clinically isolated syndrome (CIS) is a first episode of neurologic symptoms 
caused by demyelination and inflammation in the CNS. By definition, the episode must last for at 
least 24 hours. In addition, the episode should be characteristic of MS but not yet meet the 
diagnostic criteria of MS. People who experience CIS may or may not eventually develop MS. 
Relapsing-remitting MS (RRMS), the most common disease course (85-90%), is defined as 
patients have relapses of MS and periods of stability in between relapses. Secondary progressive 
MS (SPMS) disease course starts with relapsing-remitting course and followed by a progressive 
worsening of neurologic function over time. SPMS evolves from over 50% of RRMS cases. 
Primary progressive MS (PPMS) is characterized as continues worsening of neurologic function 
from the onset of the MS symptoms. PPMS occurs in about 10% of MS patients. 
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The exact cause for MS has not been identified. MS is likely caused by a combination of genetic, 
environmental, infectious factors and vascular problems [5, 6]. MS presents a rather complex 
pathology. Currently, it is thought to be autoimmune [7]. Inflammatory cells from the bloodstream 
cross the blood-brain barrier to enter the CNS [7], leading to damage to myelin and axons, which 
results in symptoms and signs. People with MS (pwMS) present a wide spectrum of symptoms, 
including fatigue, difficulty moving, problems in speech or swallowing, visual problems, and 
bladder and bowel dysfunctions. MS can also cause cognitive impairment such as depression and 
unstable mood.  
Multiple Sclerosis Functional Composite (MSFC) is a standardized, quantitative assessment 
instrument to measure MS symptom severity [8]. MSFC includes the Expanded Disability Status 
Scale (EDSS) standardized neurological examination, 25-foot timed walk (25FTW) assessment of 
gait, nine-hole peg test (9HPT) assessments of bilateral upper extremity function, paced auditory 
serial addition test (PASAT) and symbol digit modalities test (SDMT) assessments of cognitive 
function. 
Lacking a clinical, laboratory, or imaging biomarker that reliably differentiate MS from other 
neurological conditions, conditions such as migraine, fibromyalgia and functional neurologic 
disorders are often misdiagnosed as MS [9-11]. Misdiagnosis of MS bears serious implications: 
the MS disease-modifying therapies may impose high risks on patients, treating physicians may 
face medicolegal claims and litigation and health care system will carry the financial burden from 
the unnecessary disease-modifying therapy [9]. To avoid the negative misdiagnosis outcomes, 





1.3 Magnetic Resonance Imaging in MS 
Magnetic resonance imaging (MRI) has been used extensively in MS diagnosis and for monitoring 
disease. Clinical T1W, T2W and Fluid Attenuated Inversion Recovery (FLAIR) images are able 
to detect focal WM lesions with high accuracy and are used in MS diagnosis [12, 13].  
 
Figure 1.6 Examples of T1-weighted image, T2-weighted image and FLAIR image of a MS patient. 
MS lesion showed hypointense signals on the T1w image and hyperintense signals on the T2-
weighted and FLAIR images. 
In T1W images, cerebral spinal fluid (CSF) appears dark, white matter (WM) appears bright, and 
grey matter (GM) in between them. MS lesions have hypointense signals on T1W images and are 
often called “black holes.” T2W images, WM appears dark, CSF appears bright, and GM in 
between them. MS lesions are always brighter than WM. In T2W images, both MS lesions and 
CSF are bright, making lesion detect more difficult. To solve this problem, CSF signals are 
suppressed in FLAIR images, making MS lesions readily detectable. FLAIR is frequently used to 
scan MS patients in clinical practice.  
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With the gadolinium (Gd) based contrasting agent, T1W images are also used to detect “active 
lesions.” Since the contrasting agent will decrease T1 relaxation constant, the post-contrast T1W 
images will have hyperintense signal in blood vessels. In the area where blood-brain barrier (BBB) 
breaks down, Gd will diffuse into nearby tissue, generating hyperintense signals. The Gd-enhanced 
lesions are considered as “active lesions” since BBB breakdown allows immune cells to infiltrate 
the brain tissue, causing myelin and axon damage.  
Lacking specificity to MS pathology [14], these widely used “conventional” MRI measurements, 
correlate only modestly with MS disability [15, 16]. Since myelin plays an important role in the 
pathologies of MS, many magnetic resonance studies aimed to measure myelin content in vivo. 
There are generally four main approaches for MR scientists to assess alterations in myelin content.  
The first approach is to investigate myelin structures directly. The targets of this approach are the 
nonaqueous protons in the myelin lipids, such as the methylene group, or phosphorous atoms in 
the myelin structure itself. However, measuring the nonaqueous protons in myelin directly is 
challenging, since the MR signal from these protons decays in the order of a few tens of 
microseconds. In addition, signals from water will contaminate signals from nonaqueous protons 
in myelin. Nevertheless, several studies have succeeded in quantifying the signals from myelin. 
Using ultrashort echo time imaging, a few studies [17] were able to measure the ultrashort T2 
component in neuro tissues. In particular, one study pointed out that the methylene group in myelin 
lipid is the sources for the ultrashort T2 signal [18]. In addition, 31P spectroscopy was able to show 
information that can be derived about phospholipids in bilayer phospholipids, allowing us to assess 
the myelin integrity. The major shortcoming of this technique is the difficulty to quantify the signal 
from phosphatidylcholine head groups. 
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The other three approaches are to assess myelin content indirectly. The target of the second 
approach is the fraction of protons from water trapped between myelin layers (so called “myelin 
water”). Using multi-exponential T2 analysis of 32-echo spin-echo MRI data, MacKay et al. [19] 
quantified myelin water fraction (MWF) in MS patients in vivo. Subsequent histopathological 
studies showed that MWF correlated with myelin content [20, 21]. These studies have helped 
validate MWF as a biomarker to assess myelin content in neuronal tissues. The most often cited 
drawbacks of MWF imaging using spin-echo sequences are the single-slice imaging capability and 
long acquisition time [22]. To address these drawbacks, several other MRI techniques, such as 
gradient and spin-echo (GRASE) [23], T2 preparation [24], multigradient echo (MGRE) [25], 
multicomponent driven-equilibrium single-pulse observation of T1 and T2 (mcDESPOT) [26] and 
linear combination of myelin imaging [27], have been developed to study MWF. All of these newer 
techniques are able to acquire MRI data with multislice or whole brain coverage that are sensitive 
to MWF, within 30 minutes. Except for the mcDESPOT technique, most of the newer techniques 
to measure myelin water do not take the exchange of magnetization between water in different 
microanatomical compartments into consideration. This could undermine the claim that MWF is 
a quantitative measurement of myelin content. Detail review of Myelin Water Imaging is provided 
in a recent paper by Alonso-Ortiz et al [22]. 
The target of the third approach are the protons that are bound to macromolecules. Given the T2 
of the bound protons is on the order of microseconds, the bound proton signal is not typically 
measured directly. Magnetization transfer (MT) imaging [28, 29] has been widely used to assess 
the bound protons. The majority of MT studies were based on the MT ratio (MTR) which measures 
the relative signal intensity decrease due to off-resonance radiofrequency saturation of protons 
bound to macromolecules.  In MTR measurements, a two-pool model (free water and bound water) 
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has been commonly used. Since both relaxation within each proton pool and cross-relaxation 
between free water and bound water contribute to MTR, this technique still lacks pathologic 
specificity and does not have a large dynamic range of disease-related changes [30]. Unlike MTR, 
quantitative MT (qMT) experiments measure myelin bound pool fraction (BPF) [30-33], which 
offered improved specificity toward MS pathology. Several studies have shown that BPF 
correlates with myelin content [34, 35]. The limitations of qMT experiments generally include 
long acquisition time and high energy deposition (especially at magnetic fields 3T and higher). 
The need of quantitatively measuring MT effects safely and with high resolution prompts 
searching for novel MRI techniques. 
The fourth approach to study myelin integrity is diffusion tensor imaging (DTI) [36]. DTI 
measures the rate and direction of movement of water molecules within tissues. In white matter, 
axonal tracts and myelin sheathes serve as physical barriers that impose directionality or anisotropy 
on water diffusion [37]. The fractional anisotropy (FA) and apparent diffusion coefficient (ADC) 
can be used to extract general information regarding organization of fiber tracts, but are unable to 
differentiate axon and myelin damage [37]. In a mouse model of retinal ischemia, Sun et al. [38] 
demonstrated that a decrease in axial diffusivity corresponding to axonal degeneration, which 
created barriers to longitudinal movement of water molecules. In addition, an increase in radial 
diffusivity corresponded to myelin loss, which facilitated water diffusion perpendicular to axons. 
Both interpretations were confirmed by histology [38]. In human studies, radial diffusivity was 
also shown as a promising biomarker of myelin status [39, 40]. Axial diffusivity seems to correlate 
with axonal degeneration in early stages of MS. With longer disease duration, increased axial 
diffusivity was observed [41]. In summary, radial and axial diffusivities are able to characterize 
pathological changes in axons and myelin structures, particularly in early and acute phase of MS. 
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Future work should improve axial diffusivity’s capability to unravel the complex mechanism of 
axonal damage and repair.  
Our laboratory developed two quantitative MRI techniques: Gradient Echo Plural Contrast 
Imaging (GEPCI) and Simultaneous Multi-Angular-Relaxometry of Tissue (SMART). These two 
MRI techniques, based on gradient recalled echo (GRE) sequences, allow quantitatively assess 
tissue damage in both normal-appearing tissues and MS lesions. The following chapters will 
explain these two MRI techniques in detail and evaluate their candidacy as biomarkers for MS. 
 
 
1.4 Effects of Macromolecules on the Relaxation Times and Magnetization 
Transfer (MT) 
The central nervous system has two types of tissue: white matter (WM) and grey matter (GM). 
GM contains the cell bodies, dendrites and axon terminals. WM is made of myelinated axon 
bundles, serving the function of transmitting signals. The T1 and T2 relaxation time constants are 
shorter in WM than in GM. In addition, WM has stronger macromolecular proton MT effect, 
compared with GM [42]. Macromolecular such as lipids and proteins are contributing factors to 
these differences. For instance, the lipid content in WM and GM are about 49-66% and 36-40%, 
respectively [43]. The higher lipid content level as well as higher concentration of certain lipids 
make the T1 and T2 relaxation in WM faster than in GM, and contribute to more pronounced MT 
effect in WM. The following two sections will discuss the relaxivity of protons in lipid, protein 
and carbohydrate solutions.  
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1.4.1 Relaxivity and MT of lipids 
Using the multilamellar vesicle (MLV) suspensions model, Kucharczyk et al. systematically 
studied the effects of different major lipid components of white matter on relaxation times and MT 
[42]. In all cases, increased concentration of MLV caused a decrease in relaxation times and an 
increase in MT effect. Among phosphatidylcholine, galactocerebroside, cholesterol and 
sphingomyelin, galactocerebroside showed the strongest effect on relaxivity and MT. These effects 
are likely due to the large number of hydroxyl groups and the unique conformation of the 
hydrophilic head groups in galactocerebroside. Additionally, a decrease in pH caused an increase 
in MT an enhanced relaxation, suggesting that MT does not occur exclusively through spin 
exchange mechanism. Chemical exchange of labile protons also contributes to relaxivity and MT.   
1.4.2 Relaxivity of protein and carbohydrate solutions 
Like lipids, proteins can also contribute to MR signal relaxation. Using spin echo sequence, we 
measured the transverse signal decay rate constant R2 of aqueous bovine serum albumin (BSA) 
solution. In figure 1.7, R2 showed a strong linear dependence on the concentration of aqueous 
BSA solutions. The increased R2 at high protein concentration can be explained by intermolecular 
dipolar interaction between proteins and the water oriented on the protein surface, as well as 
intramolecular dipolar interaction between water trapped on the protein surface. Hills et al. 
demonstrated that transverse proton relaxation in BSA solutions can be explained by the fast 
chemical exchange between water and labile protein protons such as hydroxyl and amine 
protons[44]. The paper also claimed that the chemical exchange is the predominant mechanism for 




Figure 1.7. The transverse signal decay rate constant R2 at different protein concentrations. Data 
was collected on a Varian 500 MHz NMR instrument.  
Similar to protein solutions, another study showed that transverse water proton relaxation is 
dominated by chemical exchange between water and hydroxyl groups of carbohydrate [45]. In 
addition to chemical exchange, diffusion coefficients, local magnetic field gradients and particle 






Chapter 2: Introduction to Gradient Echo 
Plural Contrast Imaging and Simultaneous 
Multi-Angular-Relaxometry of Tissue 
2.1 Gradient Echo Plural Contrast Imaging (GEPCI) 
The GEPCI technique is based on a 3-dimentional GRE sequence and a set of post-processing 
algorithms [46-51]. The output of GEPCI includes naturally co-registered images and quantitative 
maps with various contrasts reflecting biological tissue anatomic and microstructural properties.  
2.1.1 Data acquisition 
All the GEPCI data were acquired at a 3T Trio MRI scanner (Siemens, Erlangen, Germany). A 3-
dimentional GRE sequence and a 32-channel phased-array head coil were used to obtain the data. 
Sequence parameters were: resolution 1×1×2 mm3 (readout, phase encoding, slab), FOV 256 
mm×192 mm, repetition time TR = 50ms, flip angle 30°, 10 gradient echoes started at TE1 = 4 ms, 
echo spacing ∆TE = 4ms. In order to correct the artifacts caused by physiological fluctuations [49], 
additional phase stabilization echo was collected for each line in k-space. The total acquisition 
time of the GEPCI protocol was 11 mins 30s.  
2.1.2 Image construction by combining multi-channel data 
The multi-channel GEPCI data was first transformed into the image domain using fast Fourier 
transform, and then combined using a previously developed algorithm [47]:  
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                                      (2.1) 
where index n enumerates gradient echoes, M enumerates the total number of RF channels, m 
enumerates RF channels, ( )comb nS TE is a combined signal corresponding to echo time nTE , 
( )m nS TE represents signals from each individual channel corresponding to echo time nTE . 
Parameter m is defined as: 
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,                                                       (2.2) 
where m represents the amplitude of noise in channel m, estimated by averaging the magnitude of 
10X10 pixel area at the corner of images from each channel. Since the noise levels between 
different echo times are similar, they are averaged to obtain m for each channel.  
Since the GEPCI technique collects complex data, the following generalized algorithm is used for 
data combination: 
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    ,                                (2.3) 
where 1( )mS TE is the complex conjugate of the complex signal from channel m at 1TE . Since the 
signal phases of different channels have different initial values but the same frequency, this 
algorithm for combing signals from different channels allows for the optimal estimation of 
quantitative parameters [47, 52], and also removes the initial phase incoherence among the 
channels [47].  
 
2.1.3 Correcting macroscopic magnetic field inhomogeneity with Voxel Spread 
Function (VSF) 
One of the major advantages of gradient echo sequences is its efficiency. However, images 
generated from gradient echo sequences can be affected by macroscopic magnetic-field 
inhomogeneities. In order to overcome this problem, a voxel spread function has been developed 
[48]. 
A 1-dimension gradient echo experiment is used to explain how the VSF works. In the presence 
of a macroscopic magnetic-field inhomogeneity, the MRI signal can be described in the following 
equation:  
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where ( ; )x TE  is the “ideal” signal at the continuous location x in the absence of magnetic field 
inhomogeneities, TE represents echo time, x is the location of a voxel in the image domain, kx is a 
voxel in k-space domain, xG  represents the read-out gradients, xt is the duration of the read-out 
gradient and 0 ( )x is the phase shift of the signal at time zero (mainly caused by RF field 
inhomogeneities). Notice here, the time is represented as TE+t, where t is the time during gradient 
echo acquisition (t=0 corresponds to the center of the gradient echo).  
The previous equation has to be converted to a discrete equation to describe the signal in each 
voxel. Since the size of a voxel is way smaller than scale of the macroscopic magnetic field 
inhomogeneity, the distribution of ( )b x  and 0 ( )x  in the mth voxel can be described in the 
following linear equations: 
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 where mb  and 0,m  are constants within the mth voxel but vary over voxels, mxg and mx  are the 
background gradient within the mth voxel. The “ideal” signal in the mth voxel ( )m TE  can be 
represented as a sum of ( ; )x TE  across the volume (V) of the voxel.  
                                                               ( ) ( ; )m mTE V x TE     ,                                          (2.6) 
where ( ; ) mx TE  is the averaged signal in the mth voxel. The signal is first integrated across 
x in a single voxel and then the integral is plugged into Equation (2.4):  
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Inverse Fourier transform is used to transform the data from k-space to the image domain. The 
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The overall signal in the nth voxel is related to all voxels in the image domain. 
In order to simplify the calculation, we assume that the signals from neighboring voxels have 
similar behaviors in the absence of magnetic field inhomogeneity: 
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Equation (2.8) can then be reduced to: 
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where ( )nF TE represents the VSF that accounts for the influence of magnetic field inhomogeneities. 
The one-dimensional VSF can also be applied into 2-dimensional and 3-dimensional situations.  
The following figure demonstrates that the VSF approach can significantly reduce the artifacts on 







Figure 2.1. R2* map without VSF correction (left) and with VSF correction (right) from a healthy 
subject (obtained in our laboratory). At air/water interface (nasal area), magnetic field 
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inhomogeneity contributed to bright artifacts that covered the underlying structures. After applying 
the VSF, the artifact at the nasal area was successfully corrected. 
   
 
2.1.4 Basic GEPCI images  
The major outputs of GEPCI technique are R2* (1/T2*) map, frequency map and T1-weighted 
images. They are determined by analyzing the combined data voxel-by-voxel using the following 
model:  
                   *0 1 1( ) exp 2 ( ) 2 ( ( )S TE A R TE TE i f TE TE F TE           ,                 (2.11) 
where A0 is the T1-weighted image, TE is the gradient echo time, Δf is the frequency shift (depends 
on both tissue structure and macroscopic magnetic field inhomogeneities),  F(TE) represents the 
VSF which corrects the influence of macroscopic magnetic field inhomogeneities [48], and R2* is 
the transverse signal decay rate constant. Examples of T1-weighted and R2* images are shown in 
the following figure.  
 
Figure 2.2. Examples of axial GEPCI T1-weighted and R2* maps from a healthy subject. 
Derived contrast images such as fluid suppressed T2* images and susceptibility weighted image 
(SWI) like images, can also be constructed using the equations listed in [51]. Since these derived 




2.2 Quantitative Blood-oxygen-level dependent (qBOLD) imaging 
2.2.1 Blood-oxygen-level dependent (BOLD) effect  
After removing the macroscopic magnetic field inhomogeneity, the R2* determined from equation 
[2.11] provides quantitative assessment of tissue microstructural properties. However, this R2* is 
still subject to the influences of other susceptibility effects, which might be able to provide 
information about the tissue on the cellular level. One of the essential susceptibility effects on MRI 
signals is the blood-oxygen-level dependent (BOLD) discovered by Ogawa [53]. Hemoglobin (Hb 
or Hgb) is an oxygen-transporting protein containing iron (Fe). When oxygen is bound to 
hemoglobin, the protein complex is diamagnetic with susceptibility at -9 ppm, similar to the 
susceptibility of water in tissues. After releasing oxygen to support cellular metabolic processes, 
the protein complex becomes paramagnetic, which a susceptibility at 0.15 ppm.The difference 
between magnetic susceptibility of the two states of hemoglobin distorts the local magnetic field, 
contributing to additional signal decay.  
Since BOLD effect causes variations in MRI signal that occur with physiological state-dependent 
changes in blood flow and/or oxygen consumption, a method that allows separation of tissue-
cellular-specific (R2t* relaxation rate constant) from BOLD contributions to total GRE MRI signal 
decay rate constant (R2*) is needed. In order to solve this problem, a quantitative MRI-based 
approach has been developed [54]. This approach was originally used to describe NMR signal 
behavior with the in magnetically inhomogeneous tissues. This approach suggests that the signal 
decays exponentially and the relaxation rate depends nonlinearly on echo time when echo time is 
shorter than a characteristic time tc. When the echo is longer than tc, the signal follows a simple 
exponential decay and the relaxation rate constant does not depend on the echo time. These signal 
behaviors allow the separation of BOLD effect from total signal decay rate constant R2*.  
Several subsequent studies have been published to support this approach by performing phantom 
studies [55], measuring blood magnetic susceptibility [56], testing in an animal model [57], 
analyzing systematic errors due to diffusion effects [58] and errors due to noise in the data [59, 60] 
2.2.2 qBOLD model for the blood vessel network 
Two assumptions have been made to describe the signal behavior in the presence of BOLD effect. 
The first assumption is that water diffusion can be ignored and the second is that blood vessels are 
a set of cylinders with infinite length and randomly distributed radiuses.  
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The GRE signal decay due to the presence of blood vessel network with deoxygenated blood [54] 
can be described as: 
                                           ( ) exp[ ( )]BOLD sF TE f TE     .                                      (2.12) 
In practice, we use a recently proposed a new expression [50]: 
                              
1
( ) 1 ( ) ( )
1 1




       
 
,                    (2.13) 
that better accounts for the presence of large vessels in the voxel than the traditional exponential 
function [54].   represents the deoxygenated cerebral blood volume fraction (dCBV) and   is 
the characteristic frequency determined by the susceptibility difference between deoxygenated 
blood and surrounding tissue[54]:   




B Hct Y                                          (2.14) 
where  Y is the blood oxygenation level (with Y=0 being fully deoxygenated), Hct is the blood 
hematocrit, γ is the gyromagnetic ratio, 0 0.27x ppm   [56] which is the susceptibility difference 
between oxygen saturated and fully deoxygenated blood. Function sf  describes the signal decay 
caused by the blood vessel network which was defined in [54]. Herein we use a mathematical 
expression for function sf  in terms of a generalized hypergeometric function 1 2F  [61]:  
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The function is nonlinear when 1TE   . However, when 1TE   , the function is linear, 




Figure 2.3 Function s
f
versus TE  . The dots are values at our echoes (t = TEn) assuming Y=60%. 
2.2.3 Summary 
In summary, the following model was used to describe signal decay in GRE sequence: 
       *
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where TE is the gradient echo time, R2t* (1/T2t*) is the tissue-cellular-specific transverse 
relaxation rate constant (describing GRE signal decay in the absence of BOLD effect), Δf is the 
frequency shift (depends on tissue structure and macroscopic magnetic field inhomogeneities), 
( )BOLDF TE  describes GRE signal decay due to the presence of blood vessel network with 
deoxygenated blood (veins and the part of capillaries adjacent to veins), and F(TE) represents VSF 
that describes signal decay due to macroscopic magnetic field inhomogeneities. 
By fitting the equation to the real and imaginary parts of the complex signal using nonlinear 
regression algorithm, we are able to find the six parameters: A0, R2t* and Δf for each voxel in the 
brain.  




Figure 2.4. Examples of axial GEPCI T1-weighted (a) and R2t* (b) maps from a healthy subject. 
 
2.3 Simultaneous Multi-Angular-Relaxometry of Tissue  
Simultaneous Multi-Angular-Relaxometry of Tissue (SMART) is a novel quantitative MRI 
technique based on a gradient recalled echo MRI sequenc with multiple flip angles and multiple 
gradient echoes [62]. The theory of SMART technique takes into consideration cross-relaxation 
between “free” and “bound” protons to macromolecules, generating co-registered macromolecular 
proton fraction (MPF) map, longitudinal and transverse relaxation rate constant maps and proton 
density map.  
2.3.1 Background 
Myelin is the multi-layer protective coating around axons in the central nervous system. Since 
myelin damage is the pathological hallmark of MS, many MRI techniques have been developed to 
measure myelin integrity. Due to the multi-layer structure, water in myelin has been divided into 





Figure 2.5 Structure of myelin and MR signal relaxation properties of water at different regions of 
myelin. 
Magnetization transfer (MT) has been widely used to assess myelin content. In MT studies, a 
model of two cross-exchanging pools has been commonly used: a free pool, consisting of highly 
mobile protons associated with intracellular and extracellular water with long T2 (in the range 10 
- 100 ms), and a bound pool, consisting of less mobile protons with an ultrashort T2 (less than 1ms) 
associated with macromolecules and membranes in biological tissues. Given its ultrashort T2, 
measuring signals from the bound pool is challenging. However, the exchange between the free 
pool and the bound pool allows indirect measurement of the bound pool using MT effects. Loss of 
myelin leads to decreased concentration of macromolecules and a consequent decrease of the 
bound pool.   
Many MT studies have used the MT ratio (MTR) which measures the relative MRI signal intensity 
decrease in the presence of an off-resonance radiofrequency pulse causing saturation of the 
longitudinal magnetization of protons bound to macromolecules and consecutive transfer of this 
reduced magnetization to the free water.  MTR depends on MRI pulse sequence parameters and is 
not quantitative. Unlike MTR, quantitative MT (qMT) experiments is independent of pulse 
sequence parameters. They measure the fraction of bound protons versus total protons in both free 
and bound pools. This fraction has been called the Macromolecule Proton Fraction (MPF) [30-33]. 
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Although only protons that can dynamically exchange with protons in free water can participate 
in the MT process, qMT offers improved specificity for myelin content and several studies have 
shown that qMT-defined MPF correlates with myelin concentration [34, 35].  However, qMT is 
limited by long acquisition times, low resolution, and high RF energy deposition (especially at 
magnetic fields 3T and higher).  
The SMART technique has been developed to address these limitations. Within 16 minutes, the 
SMART technique generates high resolution (1x1x1 mm3) quantitative MPF images along with 
naturally co-registered quantitative images of longitudinal (R1=1/T1) and transverse (R2*=1/T2*) 
signal relaxation rate constants images, and spin density image. Importantly, no MT pulse was 
used in the SMART protocol, making it safe in high-field MRI scanners. 
2.3.2. MRI Data Acquisition 
MRI data were collected using a 3T Trio MRI scanner (Siemens, Erlangen, Germany) equipped 
with a 32-channel phased-array head coil. SMART data of voxel size 1x1x1 mm3 were acquired 
using three dimensional multi-gradient-echo sequences with five flip angles α (5°, 10°, 20°, 40°, 
60°) and three gradient echoes (echo times 2.3, 6.2, 10.1ms) for each α. GRAPPA algorithm (16) 
with an acceleration factor of two and 24 auto-calibrating lines in each phase encoding direction 
was used. The scan time for SMART data was 13 minutes 40 seconds (2 minutes 44 seconds per 
flip angle). 
2.3.3. Phase-Sensitive B1 Mapping 
Measuring B1 radiofrequency field accurately plays an important role in the SMART technique. 
Several methods have been proposed to measure B1, either based on the magnitude [63, 64] or 
phase [65, 66] of the MR signal.  
In the SMART study, a phase-based B1 mapping technique accounting for the effects of imperfect 
RF spoiling and magnetization relaxation was implemented [67]. The technique is based on a 
multi-gradient-echo sequence with two successive orthogonal RF excitation pulses followed by 
the train of gradient echoes measurements. More detailed explanation could be found at [67].  
2.3.4. SMART Images 
The multi-channel MRI data were combined using a previously published algorithm [51]. The 
combined data were then analyzed voxel-by-voxel using the SMART model, which generalized 
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the classical Ernst model by taking into account cross-relaxation effects between “free” and 
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In equations [2.17] and [2.18], S0 is a spin density of free water; F(TE) represents the part of the 
signal decay due to the macroscopic field inhomogeneities (voxel spread function (VSF) approach 
[48] used to account for these effects); subscripts “f” and “b” indicate “free” and “bound” water, 
R1, R2* and k are longitudinal, transverse and cross-relaxation rate constants respectively; τ is the 
RF pulse duration. The factor ν depends on the RF pulse shape and is equal to one for rectangular 
pulses used herein.  
By fitting the theoretical model in Eq. [2.17] to experimental data on a voxel-by-voxel basis, the 
five parameters S0, R1, fk   ,   , and R2* were determined.  The fraction of “bound” protons, MPF 
[30, 32], was calculated from the equilibrium principle  (1 )f bk MPF k MPF     : 
      / ( )f f bMPF k k k       (2.19) 
Using Eq. [2.18], MPF can then be expressed in terms of parameters available from [2.17] and 
[2.18]:   
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Since the ratio   1 2b bR R    is much smaller than 1 [62], we used the following simplified 
equation for data analysis: 










                                              (2.21) 
In Eq. [2.21] we fixed the parameter 1bR   to 1.84 s
-1 in agreement with previous estimates [68]. 
 
2.3.5 Summary 
In summary, without applying either MT or 180° radiofrequency pulses, the SMART technique 
can simultaneously generate high resolution quantitative images of MPF, R1 relaxation rate, R2* 
relaxation rate and spin density and is safe for high-field MRI. SMART MRI would be a useful 













Chapter 3: Single Scan Quantitative Gradient 
Recalled Echo MRI for Evaluation of Tissue 
Damage in Lesions and Normal Appearing 
Gray and White Matter in Multiple Sclerosis 
3.1 Introduction: 
Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system (CNS) that 
involves the brain and the spinal cord, often causing neurologic disability. MRI plays an important 
role in MS diagnosis[69], as an endpoint in clinical trials[70], and as a means to monitor 
patients[71]. Recent MRI studies have focused on pathological changes in both macroscopic 
(visible with standard clinical MRI) lesions and normal appearing tissue (invisible with standard 
clinical MRI).  
Conventional MRI techniques can readily detect focal white matter (WM) lesions. MS plaques are 
typically bright on T2-weighted (T2W) and FLAIR (fluid attenuated inversion recovery) images 
and dark on T1-weighted (T1W) images referred to as “gray” or “black holes” that are believed to 
represent the loss of underlying tissue, especially axons[72]. New approaches, such as phase-
sensitive inversion-recovery (PSIR)[73], target MS lesions in gray matter (GM). A limitation of 
these images is that although they can be used to detect MS lesions, they cannot be used to quantify 
the severity of tissue destruction. Indeed if T2W or T1W images indicate that two MS lesions have 
identical volumes, this does not mean that the two lesions have the same underlying pathology. In 
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addition, neither normal-appearing white matter (NAWM), which is often abnormal histologically, 
nor normal-appearing GM (NAGM) can be identified on T2W or T1W images of MS subjects[74]. 
In addition to brain pathology, over 90% of MS patients develop spinal-cord lesions, and these 
cord lesions can greatly impact neurologic disability[75, 76]. 
Because of this, new approaches utilizing quantitative maps of T2 and T1 relaxation time constants, 
magnetization transfer ratio (MTR) and diffusion have been proposed[19, 77-80] in addition to 
standard subjective T2W and T1W images. However, for reasons such as long imaging times, low 
resolution and low signal-to-noise ratio (SNR), these are not commonly used for MS in clinical 
practice. Hence, fast, quantitative noninvasive imaging methods that reflect severity of MS 
pathology, both in lesions and normal appearing tissue, are needed for prognostication and to 
monitor patients[70, 81]. 
Our approach to this problem is based on quantitative measurements of the transverse relaxation 
properties of the Gradient Recalled Echo (GRE) MRI signal. This quantitative GRE (qGRE) 
approach[82], an advanced version of previously developed Gradient Echo Plural Contrast 
Imaging (GEPCI) technique[51], allows estimation of tissue damage in MS lesions and normal 
appearing WM and GM. An innovative qGRE method of data analysis[82] allows separation of 
tissue-cellular-specific (R2t* relaxation rate constant) from Blood Oxygen Level Dependent 
(BOLD)[53] contributions to the total GRE MRI signal decay rate constant (R2*). Since BOLD 
effect causes variations in MRI signal that occur with physiological state-dependent changes in 
blood flow and/or oxygen consumption, the R2t* values more specifically reflect the tissue-cellular 
component of R2*. The tissue-cellular-specific (R2t*) MRI relaxation parameter depends on the 
environment of water molecules (the main source of MRI signal): higher concentrations of proteins, 
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lipids, and other constituents of biological tissue and cellular constituents (sources of MRI signal 
relaxation) leading to higher relaxation rate constants.  
qGRE method that we use also includes acquisition and post-processing approaches that minimize 
adverse artifacts related to macroscopic magnetic field inhomogeneities[48] and physiological 
fluctuations[83]. From these perspectives, the transverse relaxation rate constant R2t* of the GRE 
signal is a close relative of the transverse relaxation rate R2 of the spin echo signal but qGRE 
approach allows much faster imaging with higher resolution and SNR. Prior studies in autopsied 
MS CNS tissue demonstrated statistically significant correlations between T2 (1/R2) relaxation 
time constants and MS pathology both for the spinal cord[84] and brain[21, 85]. Due to the 
similarity between R2 and R2t*, we can conclude that R2t* measurements can serve as a 
pathological correlate of tissue damage in MS. Besides, measurements in autopsied samples also 
confirmed correlation with MS-related tissue damage in GM[86].  
In this paper, we evaluate the novel MRI biomarker R2t* for quantitative detection of normal-
appearing tissue damage in MS patients. We also investigate correlations between loss of tissue 
quality in different regions of central nervous system that could suggest the topographic signatures 
of tissue damage in MS patients. 
 
3.2 Materials and methods: 
3.2.1 Subjects 
Forty-four MS patients with relapsing remitting (RRMS, n=15), secondary progressive (SPMS, 
n=16) and primary progressive (PPMS, n=13) MS clinical courses and 19 healthy control (HC) 
subjects were enrolled, after providing informed consent. HC were recruited to reflect the gender 
and age distribution of the MS patients. The study was approved by the Institutional Review Board. 
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3.2.2 Clinical testing 
The Expanded Disability Status Scale (EDSS) standardized neurological examination, 25-foot 
timed walk (25FTW) assessment of gait, nine-hole peg test (9HPT) assessments of bilateral upper 
extremity function, and paced auditory serial addition test (PASAT) and symbol digit modalities 
test (SDMT) assessments of cognitive function were performed on the day of the MRI by 
examiners blinded to imaging results. For analyses, the 25FTW and 9HPT were converted to Z 
scores according to the following equations from Multiple Sclerosis Functional Composite 
(MSFC)[8]: 
                                         Z25FTW= (25FTW-9.5353)/11.4058                                      (3.1) 
                                                 Z9HPT= (1/9HPT -0.0439)/0.0101                                        (3.2)                                                                                     
3.2.3 Image acquisition 
MRI scans were performed on a 3.0 Tesla (3T) Trio MRI scanner (Siemens, Erlangen, Germany) 
using a 32-channel phased-array RF head coil. Previously developed GEPCI protocol[51] with 
navigation echo[83]  was used to acquire a three dimensional (3D) multi-gradient-echo data with 
flip angle of 30°, TR=50 ms, voxel size of 1×1×2 mm3 and acquisition time of 11 min 30 s. For 
each phase encoding step, 10 gradient echoes and one navigation echo[83] were collected with 
first echo time TE1 = 4 ms and echo spacing ΔTE = 4 ms. Standard clinical MPRAGE[87] images 
with voxel size: 1×1×1 mm3 were collected for segmentation purposes and measuring cortical 
thickness (TH) and spinal cord cross-sectional area (CSA). Fluid-attenuated inversion recovery 
(FLAIR) sequence with voxel size of 1×1×3 mm3 was used for outlining WM lesions.  
3.2.4 Image processing and segmentation 
The MRI data were analyzed using qGRE approach described in a previous study[82]. Details are 
presented in the supporting information. In brief, multi-channel data were combined using GEPCI 
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algorithm[51] and analyzed voxel-wise using the theoretical model of GRE signal relaxation[54, 
88], and a set of post-processing algorithms that minimize adverse artifacts related to macroscopic 
magnetic field inhomogeneities[48] and physiological fluctuations[83]. This approach allows 
generation of images and quantitative maps with several contrasts reflecting biological tissue 
anatomic, microstructural and functional properties. In this study we use GEPCI T1w images and 
qGRE R2t* maps. Importantly, all these images are inherently co-registered. 
Brain GM and WM segmentation was performed on MPRAGE images using FreeSurfer 5.3.0 
(Martinos Center for Biomedical Imaging, MGH/HST, US) with visual inspection of each 
segmented region of interest (ROI) for accuracy.  It resulted in 68 cortical GM and 68 
corresponding subcortical WM ROIs (for each ROI, the R2t* and TH in left and right hemispheres 
were averaged). A list of ROIs is provided in the supporting information. MPRAGE images were 
co-registered with GEPCI-T1w images (which are intrinsically co-registered with qGRE R2t* 
maps) using FSL 5.0.0 software (Analysis Group, FMRIB, Oxford, UK). This procedure also co-
registered ROIs generated by FreeSurfer to GEPCI-T1w images and R2* maps. To minimize 
partial volume effects, CSF masks were generated based on the GEPCI T1w images using FSL. 
Applying regional and CSF masks, median values of R2t* and of cortical GM thickness were 
calculated for each cortical ROI.  3D MPRAGE data were processed using PropSeg (Spinal Cord 
Toolbox version 2.0)[89] to measure the spinal cord CSA. Mean CSA values at the four upper 
cervical levels were calculated.  
3.2.5 Tissue Damage in MS Lesions based on R2t* 
For all subjects, MPRAGE and FLAIR images were registered using FSL and used to obtain WM 
lesion masks using “lesion-TOADS” tool[90] in Medical Image Processing, Analysis and 
Visualization (MIPAV)[91]. For each subject, tissue damage within WM MS lesions was 
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quantified in terms of tissue damage load (TDL) – parameter calculated based on the difference 
between R2t* values of voxel within the lesions and R2t* values of NAWM, similar to a previous 
R2*-based report[92] (details in the supporting information).  
3.2.6 Statistical analysis 
Statistical analyses and correlations were performed using MATLAB (The MathWorks, Inc.).  
Median R2t* values were used to describe each FreeSurfer region in the brain, because R2t* values 
in most regions were not normally distributed and also to minimize edge/partial volume effects 
and spurious values. Age is known to affect R2t* and reduce cortical thickness[60], therefore, age-
dependent R2t* and cortical thickness values were obtained from the HC cohort of 19 individuals. 
To account for this effect, the median values of R2t* in each of Free Surfer cortical or subcortical 
region (n) in the normal HC group were fitted by a linear equation:[60] 
                                                 ( )n n nMedianValue A K age age                   (3.3) 
where <age> is mean age of HC group. Introducing it in the equation, assigns to parameters An 
values corresponding to mean age of participants. This procedure allowed calculation of expected 
reference regional values for any actual patient age. Similar procedure was used for subcortical 
WM and FreeSurfer-defined cortical thickness. These calculated values were subtracted from the 
values of individual HC and MS subjects to generate ΔR2t* and ΔThickness. Spinal cord area was 
not significantly correlated with age in our data (parameter K =0 in Eq. (3.3) and no significant 
difference of spinal cord area between male and female groups was found. Thus, the mean CSA 
value of the entire HC cohort was subtracted from each MS subject CSA values to generate ΔCSA. 
Due to the small number of male patients (Table 1) gender differences were not taken into account. 
For spinal cord, no significant correlation was found between spinal cord CSA and age, height, 
brain size and disease duration, so these variables were not considered in subsequent data analyses.  
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To explore topographic signatures of tissue damage in NAGM, Person’s Correlation analysis was 
performed between ΔR2t* of each cortical region (n) and ΔR2t* of the mean global cerebral NAGM 
for all MS patients (without separation on MS sub-groups). Similar analysis was repeated for 
NAWM and cortical thickness. 
To examine correlation between tissue damage in brain and spinal cord, Pearson’s correlation 
analysis was performed between ΔCSA of C1 and ΔR2t* of each cortical region, ΔCSA of C1 and 
ΔR2t* of each subcortical WM region, and ΔCSA of C1 and thickness of each cortical region.  
To establish relationships between MS-related tissue damage in adjacent subcortical WM and 
cortical GM regions, we applied linear regression analysis to the 44 MS patients using the 
following equation for each cortical region defined in FreeSurfer (n): 
                                                           (3.4)  
where  is a mean R2t* measurement for the entire cortical GM or subcortical WM in 
each MS patient. Equations (3.4) were applied to establish MS-related tissue damage based on all 
44 MS patients without regard to MS subtypes. 
Correlations of ΔCSA with EDSS, 25FTW and 9HPT were assessed using Spearman’s rank 
correlation since these data were not of Gaussian distribution. Parametric data were analyzed 
using Pearson’s correlation. False discovery rate (FDR) with Benjamini-Hochberg procedure 
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3.3.1 Examples of Images and Demographic Data of Participants  
Examples of GEPCI T1w images, R2t* maps, and MPRAGE images for one healthy control and 
one MS patient are shown in Fig. 3.1.  
 
Figure 3.1 Examples of axial GEPCI T1 weighted images and R2t* maps are shown along with 
sagittal MPRAGE images of one healthy control (a-c) and one MS patient (d-f). Images shown 
come from similarly aged female (58 and 55 years old) HC and MS patient. In the MS patient, two 






The age range and gender ratio was similar for HC and MS patients (demographic and clinical 
information presented in Table 3.1). As expected, the mean EDSS was less severe for the RRMS 
patients than the progressive patients (Table 3.1).  
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EDSS = Expanded Disability Status Scale; 25FTW = 25-foot timed walk (seconds); 9HPT = nine-
hole peg test (seconds);  
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Note: For the 25FTW, four MS patients could not finish the test. One MS patient could not finish 
the 9HPT (Dominant hand) and three MS patients could not finish the 9HPT (Nondominant hand). 
 
 
3.3.2 Topographic signatures of CNS tissue injury in Multiple Sclerosis 
“Visible” tissue damage (lesions in brain WM and the atrophy of the cortex and the cervical spinal 
cord) and “invisible” tissue damage (reduced R2t* in cortical NAGM and subcortical NAWM of 
MS patients) were identified and quantified. Group-wise, R2t* of GM readily distinguished HC 
from MS patients (Fig. 3.2). Cortical thickness was not significantly different between HC and MS 
groups although trends for reduced thickness were observed in the progressive MS groups (Fig. 
3.2). Decreased (1.96 standard deviations lower than mean value of HC group) R2t* of NAGM 
was present in 48% of the MS patients compared to decreased cortical thickness in only 9% of the 
MS patients. Group comparisons based on R2t* of subcortical WM, WM tissue damage load (TDL) 
and cervical spinal cord CSA (Fig. 3.3) showed significant differences between MS patients and 
HC.  There were no detectable lesions in WM of HC, hence HC TDL = 0. Decreased (1.96 standard 
deviations lower than mean value of HC group) subcortical WM R2t* was present in 43% of the 




Figure 3.2 Group comparisons based on the mean global cortical R2t* (a) and mean global cortical 
thickness (b). Cortical R2t* performs better than thickness in distinguishing MS patients from HC 
on both group and individual levels. At the individual level, decreased (1.96 standard deviations 
of HC group lower than mean value of HC group) R2t* was present in 48% of MS patients 
compared to decreased cortical thickness in only 9%. Yellow dashed lines indicate 1.96 standard 
deviations of HC group lower/ higher than mean value of HC group. Boxes represent the 
interquartile ranges; the horizontal lines within the boxes indicate median values, points are 
median values of individual patients. p<0.001 ***, p<0.01 **, p<0.05 *. All p values were 




Figure 3.3 Group comparisons based on the mean global subcortical WM R2t* (a), WM TDL (b), 
and mean CSA (c). Most MS patients showed decreased R2t* in subcortical NAWM and mean 
spinal cord CSA (averaged spinal cord cross-sectional area from C1 to C4). Yellow dashed lines 
indicate 1.96 standard deviations of HC group lower/ higher than mean value of HC group. Boxes 
represent the interquartile ranges; the horizontal lines within the boxes indicate median values, 
points are median values of individual patients. p<0.001 ***, p<0.01 **, p<0.05 *. All p values 
were determined after adjusting for multiple comparisons using false discovery rate.  
 
 
Since our measurements in cortical GM and subcortical WM did not show significant differences 
between MS subtypes, all further analyses were performed for MS patients without separation into 
MS sub-groups. Since there were no significant difference of R2t* and cortical thickness 
measurement between left and right hemisphere (see supporting information), the values of R2t* 
and TH in the left and right hemispheres were averaged for corresponding ROIs.  
The fitting results for R2t* and Thickness per equation (3.3) are listed in supporting information. 
Since not all coefficients Kn between of ROIs were statistically significant,  for further analysis we 
use the same coefficients K for all ROIs that were determined by fitting global values of R2t* and 
Thickness. These coefficients are: 0.0303 (GM R2t*), 0.0211 (subcortical WM R2t*) and -0.0052 
(GM thickness). These calculated baseline values were subtracted from the values of individual 
HC and MS subjects to generate ΔR2t* and ΔThickness. The p-values of the correlations between 
age and global mean R2t* in GM and subcortical WM, and mean cortical thickness are 0.0006, 
0.046, 0.003, respectively. 
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Not all regions of GM and WM were affected equally. To establish patterns of tissue damage 
between different cortical and subcortical ROIs, we first performed Pearson’s correlation analysis 
of ΔR2t* in each NAGM cortical region (  ) versus mean NAGM cortical ΔR2t* using data 
for all 44 MS patients. A similar procedure was performed for cortical thickness and ΔR2t* of 
subcortical NAWM. Patterns of tissue damage, as determined by r values from correlation analyses 
are presented on brain surface maps (Fig. 3.4). The patterns of tissue damage were similar for 
NAGM and subcortical NAWM: tissue damage in parietal and occipital cortices reflected best 
with mean cortical tissue damage. Cortical thickness showed a different pattern than R2t* 
measurement; changes in temporal cortices showed the strongest correlation with the mean cortex 





Figure 3.4 Topographic signatures of tissue damage in NAGM and NAWM. (a,b): r value from 
Pearson’s correlation analysis between ΔR2t* of each cortical region (n) vs. ΔR2t* of the mean 
global cerebral NAGM for all MS patients (without separation on MS sub-groups) are mapped on 
the cortical surface. Decrease of R2t* in the motor and postcentral cortex were most reflective of 
the mean global cortical decrease of R2t*. (c,d): The same analysis for subcortical NAWM. The 
pattern of change in ΔR2t* of NAWM was similar to NAGM. (e,f): The same analysis for cortical 
GM ΔThickness. Decrease of thickness in the temporal lobe correlated most with the mean 
decrease of thickness in global cortex. The surface of the cortex was generated by FreeSurfer. 
Deep GM structures, WM and ventricles were excluded. Color bars represent r value from 
Pearson’s correlation analysis. 
 
3.3.3 Interrelationships between MS tissue injury in different topographic 
region 
Figures 3.2, 3.3 and 3.4 show the presence of tissue damage in spinal cord, GM, and WM in MS 
patients. To test the hypothesis that the strength of tissue damage in different parts of CNS could 
be interrelated, thus forming MS-related topographic signatures, we ran a correlation analysis 
between all the quantitative parameters defining MS tissue damage in spinal cord, NAGM, 
NAWM and MS lesions. The sizes of spinal cord at C1, C2, C3 and C4 are highly correlated 
(Supporting information: Figure 3.7). Since only one focal MS lesion was noted at C1 level, CSA 
of C1 was used to correlate with tissue damage measurement in brain and clinical scores. 
CSA at C1, tissue damage in NAGM and NAWM in the brain, and tissue damage load of lesions 
in the brain showed multiple interrelationships, irrespective of MS clinical subtype (Table 3.2). 
Reduced R2t* values in global NAGM and subcortical NAWM were significantly correlated with 
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reduced CSA of C1 (Table 3.2). In contrast, no significant correlations between reduced CSA at 
C1 and reduced R2t* of GM or subcortical WM was seen for HC (p=0.68 and 0.88 respectively) 
suggesting that correlations in MS patients are pathology-related. Similarly, MS patients with 
smaller CSA also had proportionately thinner global cerebral cortices but no significant correlation 
was found between C1 CSA and thickness of GM for HC (p=0.52).  
In addition to the assessments of relationships between characteristics of the spinal cord and the 
brain globally (Table 3.2), specific cortical regions were also examined (Fig. 3.5). Tissue damage 
characterized by ΔR2t* of middle temporal, inferior temporal and inferior parietal cortical regions 
of NAGM showed the most significant correlations with the C1 spinal cord size. For subcortical 
NAWM, the ΔR2t* of the middle temporal region demonstrated the greatest correlation with CSA 
at C1. In contrast and not unexpectedly, among all 34 cortical regions, the thickness of the motor 
cortex was most correlated with C1 spinal cord size (Fig. 3.5). Thickness of other cortical regions 









Table 3.2 Summary of correlations between different tissue damage measurements in CNS 
for 44 MS patients. p<0.001 ***, p<0.01 **, p<0.05 *. All the p values presented after correction 
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Figure 3.5 Results of the correlation analyses between tissue damage in the brain and the spinal 
cord based on all 44 MS patients. All images show the r values of the Pearson’s correlation 
coefficient mapped on the cortical surface. (a,b): correlation between ΔCSA of C1 and ΔR2t* of 
cortical GM. The primary motor cortex and the somatosensory cortex showed moderate 
correlations with C1 ΔCSA. (c,d): correlation between ΔCSA of C1 and ΔR2t* in subcortical WM 
regions. The middle temporal subcortical WM demonstrated the highest correlations with C1 
ΔCSA. (e,f): correlation between ΔCSA of C1 and ΔThickness in cortical regions. The primary 
motor cortex showed the strongest correlation with C1 ΔCSA, while other regions either showed 
very weak or no significant correlations.  The surface of the cortex was generated by FreeSurfer. 




Table 3.2 also shows significant correlations between tissue damage measured by mean R2t* of 
NAGM and mean R2t* of the subcortical NAWM. To assess the relative severity of tissue damage 
in adjacent regions of cortical NAGM and subcortical NAWM, linear regression based on all 44 
MS patients was performed between decrease of R2t* in each subcortical NAWM region versus 
corresponding cortical NAGM regions (per Eq. (3.4) in Methods). A slope less than 1 indicates 
that NAGM R2t* has larger relative reduction than NAWM. With the exception of the inferior 
temporal cortex, all NAGM regions showed larger relative changes than NAWM (Fig. 3.6). 
 
 
Figure 3.6 Slopes of linear regressions between ΔR2t* of adjacent subcortical NAWM vs. ΔR2t* 
of matched cortical NAGM regions (parameter qn in Eq. (3.4)). Data are based on all 44 MS 
patients.  Images represent parameter qn projected on the cortical surface generated by FreeSurfer. 
Deep GM structures, WM and ventricles were excluded. Color bar represents qn values. 
 
3.3.4 Relationship between clinical test performance and tissue damage in 
brain and spinal cord in MS.  
 
Table 3.3 Summary of clinical test correlations with spinal cord size at C1, mean R2t* of 
global cortex, mean R2t* of subcortical WM, mean thickness of global cortex, and brain 
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white matter tissue damage load for the 44 MS subjects.  r is Pearson correlation coefficient, 
all the p values presented after correction for multiple comparison via false discovery rate. p<0.001 
***, p<0.01 **, p<0.05 *.  
 
 ΔCSA at C1 
Mean ΔR2t* of 
cortex 
Mean ΔR2t* of 
subcortical wm 
Mean ΔTh of 
cortex 
TDL 
 r p r p r p r p r p 
EDSS -0.61 *** -0.12    0.51 -0.080 0.65 -0.46 ** 0.36     * 
25FTW -0.62 *** -0.19    0.27 -0.16   0.36 -0.41 * 0.29   0.085 
9HPT(Dominant) 0.47 ** 0.37 *   0.21   0.22 0.26     0.14  -0.25 0.14 
9HPT(NonDominant) 0.34 * 0.53 ** 0.42 * 0.21     0.16  -0.32   0.056 
PASAT   0.051 0.77 0.45 ** 0.46 ** 0.016     0.92 -0.39 * 
SDMT 0.14 0.42 0.30 0.051 0.39 * 0.26     0.23 -0.44 * 
 
To evaluate the relationships between tissue damage and MS clinical signs, mean ΔR2t* of  NAGM 
and NAWM , mean cortical ΔTh, spinal cord atrophy (ΔCSA at C1) and tissue damage load (TDL) 
in brain WM lesions were each assessed for correlations with clinical test results (EDSS, 25FTW, 
9HPT, SDMT and PASAT) (Table 3.3).  Region-wise results are presented in the supporting 
information. ΔCSA at C1 had the most significant correlations with motor-related clinical tests 
EDSS, 25FTW, and 9HPT (dominant and nondominant hands). Similar correlations with clinical 
tests were found for C2, C3 and C4 (not shown). Mean ΔR2t* of global cortex showed significant 
correlation with 9HPT (dominant and nondominant hands) and PASAT. WM Tissue damage load 
based on R2t* correlated with EDSS, PASAT and SDMT. In the present 44 patient cohort, gender, 




In this study, we addressed three questions. One was to ask if we could detect “invisible” pathology 
not recognized by standard clinical MRI (based on “weighted” MRI contrasts) in the CNS of MS 
patients using a new imaging marker, R2t*. The second related question was to ask whether there 
existed topographic signatures of MS pathology (visible and invisible) in CNS common to MS 
patients. The third question was whether our quantitative tissue damage measurements reflected 
neurological impairment in MS.  
3.4.1 R2t* Reveals Tissue Damage not Readily Visible by Clinical MRI 
Tissue integrity in the brain cortical NAGM and subcortical NAWM of MS patients was quantified 
using the gradient recalled echo MRI signal decay rate constant, R2t*. This parameter (R2t*) is a 
quantitative measure that has been shown to correlate with tissue cellular density in normal human 
brain[60] and was decreased in brain areas in concert with the loss of tissue cellular integrity in 
Alzheimer’s disease[93]. Since previous studies demonstrated reduced R2 values in areas of 
demyelination in the spinal cord[84]  and brain[19, 85], and reduced total R2* has been noted in 
areas of WM[92] and cortical demyelination[86, 94], we expected that a more tissue-specific 
parameter R2t* would be reduced by demyelination as well. Indeed, in our cohort, MS patients 
had lower R2t* values in both WM and GM as compared with HC participants. We were able to 
identify regions of “invisible” tissue damage based on comparison of quantitative R2t* 
measurements in MS and HC participants.  The “visible” part of brain tissue damage was also 
quantitatively assessed in our study by measuring cortical thickness and a quantitative composite 
measure of WM damage characterizing both WM lesion volume and tissue damage within the 
lesions - MS lesion Tissue Damage Load (TDL). The cervical spinal cord was assessed by 
measuring upper cervical cord CSA, reductions which predominantly reflect axon loss.  
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Since age affects R2t* and reduces cortical thickness, baseline correction was used to account for 
age effects. For spinal cord, no significant correlation was found between spinal cord CSA and 
age, height, gender, brain size and disease duration in our data. 
For the first question, tissue damage of various degree not apparent on standard MRI was present 
in most MS patients in most parts of CNS we examined. Significant atrophy was present in the 
cervical spinal cord and cortical GM with the motor cortex and temporal cortex showing the most 
significant volume reductions in the brain. Although most cortical regions were affected in at least 
some patients, the motor cortex and postcentral cortex demonstrated the greatest decreased of R2t* 
compared to HC. Brain subcortical WM demonstrated a similar pattern, in accord with the strong 
correlation between R2t* in GM and subcortical WM. No significant correlation between R2t* of 
cortical NAGM and cortical thickness was found, which means that R2t* and thickness are two 
complementary measurements – the latter showing reduction in tissue volume while the former 
showing loss of remaining tissue integrity. We had hypothesized that tissue quality changes 
(measured by R2t*) should be evident before atrophy. The difference between cortical thickness 
of healthy controls and MS patients were not statistically significant, possibly due to the relatively 
small cohort size. Nevertheless, a decreasing trend of cortical thickness was observed in this study, 
which is consistent with a recent report showing group differences measured by normalized gray 
matter volume in a larger cohort of 206 MS patients[95]. Normalized gray matter volume was also 
measured in our study and similar trend as in[95] were found (Supporting Information: Figure 3.8). 
Compared with cortical thickness, R2t* measurement readily differentiated MS patients from 
healthy controls even within our small cohort size. Since more patients showed significant 
decrease in R2t* of the NAGM but not in cortical thickness, we suggest that R2t* is more sensitive 
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to tissue injury than cortical atrophy, and has a potential to be used as a sensitive biomarker for 
MS related clinical trials.  
3.4.2 Topographic Signatures of MS Pathology Have Been Identified 
To answer the second question, correlations between tissue damage in different parts of CNS were 
examined. Tissue damage in the cervical spinal cord (assessed by cord atrophy) significantly 
correlated with tissue damage in the brain cortical NAGM (assessed by cortical atrophy and 
reduced R2t*), subcortical NAWM (assessed by reduced R2t*) and WM MS lesions (assessed by 
R2t*-based Tissue Damage Load). Whereas correlations existed between tissue damage in several 
different parts of the brain and CSA of cervical cord, the strongest and the most significant 
correlation was found between atrophy of the spinal cord and the thickness of brain motor cortex.  
This was not surprising since these two structures are physically and functionally linked, with 
axons from motor cortical neurons extending through the cervical cord; when a motor neuron dies, 
its axon degenerate. 
Another interrelationship (cortical GM – subcortical WM) was identified by strong correlations 
between tissue damage in the adjacent regions of cortical GM and subcortical WM. Table 2 shows 
that decreases of R2t* in cortical NAGM and subcortical NAWM were highly correlated. We 
further examined the relative severity of tissue damage between NAGM and NAWM. Our 
measurements show that R2t* changes in GM were relatively bigger in most ROIs than in adjacent 
WM ROIs, which may suggest that tissue damage is relatively more severe in cortical NAGM 
compared with subcortical NAWM. This interpretation would be in accord with a previous study 
which found the percentage of demyelinated area was significantly higher in cerebral cortex than 
in WM of MS patients[96]. 
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It was also notable that the reduced CSA of the cervical spinal cord significantly correlated with 
“invisible” tissue damage (assessed by R2t*) in the primary motor cortex, and temporal and 
inferior parietal cortices. Interestingly, correlations with cord CSA were noted even for regions of 
cortex, such as occipital, that do not directly link to the spinal cord. Although the biological 
meaning of these correlations is not obvious, they did not exist in HC indicating that they are 
pathology-related. The significant associations between visible and invisible tissue damage in all 
parts of CNS further support the concept of MS as a global disease of the CNS.  
Certain regions of the CNS are known to be more frequently affected by MS. In particular, these 
are periventricular areas, juxtacortical white matter, corpus callosum, cortical gray matter, optic 
nerves, medial longitudinal fasciculus, cerebellar tracts, and the cervical spinal cord[97]. Although 
the current study did not examine the tissue damage in every region of CNS, our data still showed 
tissue damage patterns in the CNS of the 44 MS patients in our cohort. Whether these patterns are 
generally common to MS patients will need confirmation in larger and different MS patient cohorts. 
These data are also consistent with recent reports of correlations between spinal cord MRI 
measurement and retinal layers in multiple sclerosis[98], and associations between deep gray 
matter tissue damage and degeneration in cortex and spinal cord[99]. 
3.4.3 R2t* correlates with MS patients’ Neurological Impairments 
To address the third question, we examined relationships of tissue damage assessed by R2t* and 
cortical thickness in different parts of the CNS and C1 CSA with neurological function. A 
composite measure for tissue damage load (TDL) based on ΔR2t* values in the WM lesions 
correlated with EDSS, but to a lesser degree than cervical CSA. Of all our imaging measures, the 
cervical cord CSA correlated best with physical impairment defined by EDSS and 25FTW tests, 
in accord with several previous studies[100]. 
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Not surprising, no correlation was found in this study between cognitive tests (SDMT and PASAT) 
and spinal cord cross-sectional size.  On the other hand, ΔR2t* values of the entire cortical GM 
and several specific cortical regions correlated significantly with SDMT and PASAT scores.  
These correlations with cognitive test results were more widespread and greater than for cortical 
thickness, indicating that ΔR2t* is more sensitive to tissue damage. The region-wise analysis 
showed the correlation between GM, subcortical WM R2t* and 9HPT (Dominant and 
nondominant) were similar. However, subcortical WM R2t* showed stronger correlation with 
cognitive tests compared with GM R2t*. 
Based on these findings we can hypothesize that R2t* alterations might be an early indicator of 
MS pathology, detectable at a time when atrophy is not apparent.  In the future, we plan to create 
a model incorporating R2t* and other imaging parameters, to explain concurrent physical 
impairment status with the ultimate goal of predicting future MS course.  
In this study, we have not reported tissue-specific R2t* measurements in the upper cervical spinal 
cord due to technical issues related to low signal-to-noise ratio in our data in the spinal cord. RF 
coils covering both brain and spinal cord would allow simultaneous R2t* mapping in the brain and 
spinal cord without increased scanning time. Improvement in RF coil design could potentially 
allow R2t* mapping of small CNS structures (e.g. optical nerve) that was not visible with our 
current design. Generating R2t* maps on the scanner requires computer power that is currently not 
available from manufacturers and therefore we analyzed data off-line. While timing is crucial for 
diagnostic acute medical conditions (e.g. stroke, heart attack, etc.), delays with generating 
diagnostic images based on R2t* metric can be tolerated for chronic conditions like MS. Future 
improvement of the time to generate usable results will likely be resolved with the development 




In conclusion, we report the novel finding that a quantitative measure of MS tissue damage based 
on the tissue cellular specific transverse relaxation rate constant, R2t*, can sensitively detect MS-
related pathology in cortical NAGM, subcortical NAWM and WM lesions. The method 
demonstrated tissue damage patterns in the CNS of the MS cohort. Our data shed light on the 
interrelationships of damage throughout the brain and cervical spinal cord, while supporting the 
idea of MS as a global CNS disease. Our results showed that while spinal cord CSA is a reliable 
marker for changes in motor functions, the reduction in the  R2t* of GM and WM is a reliable 
indicator of cognitive dysfunction. 
3.6 Supporting Information: 
 
Figure 3.7. Correlations between cross-sectional areas in C1, C2, C3 and C4. First row: correlation 
between C1 and (A) C2, (B) C3, (C) C4. Second row: correlation between C2 and (D) C3, (E) C4, 
correlation between C3 and C4 is shown in (F). Data from healthy controls (black dots) and MS 





Figure 3.8. Group comparisons based on the normalized cortical grey matter volume. SPMS group 
showed statistically significant decrease of normalized grey matter compared with healthy controls. 
RRMS and PPMS also showed decreasing trend of normalized grey matter compared with healthy 
controls, even though they were not statistically significant. Progressive MS groups (PPMS and 
SPMS) also demonstrated decreasing trend compared with RRMS group. Boxes represent the 
interquartile ranges; the horizontal lines within the boxes indicate median values, points are 
median values of individual patients. p<0.001 ***, p<0.01 **, p<0.05 *. All p values were 




Figure 3.9 Results of the correlation analyses between the regional tissue damage in the brain and 
9HPT (dominant hand) based on all 44 MS patients. All images show the r values of the Pearson’s 
correlation coefficient mapped on the cortical surface. (a,b): correlation between 9HPT (dominant 
hand) and ΔR2t* of cortical GM. The somatosensory cortex and occipital cortex showed moderate 
correlations with 9HPT. (c,d): correlation between 9HPT (dominant hand) and ΔR2t* in 
subcortical WM regions. The middle temporal subcortical WM demonstrated the highest 
correlations with 9HPT. The surface of the cortex was generated by FreeSurfer. Deep GM 




Figure 3.10 Results of the correlation analyses between regional tissue damage in the brain and 
9HPT (nondominant hand) based on all 44 MS patients. All images show the r values of the 
Pearson’s correlation coefficient mapped on the cortical surface. (a,b): correlation between 9HPT 
(nondominant hand) and ΔR2t* of cortical GM. The primary motor cortex and the somatosensory 
cortex showed moderate to strong correlations with 9HPT. (c,d): correlation between 9HPT 
(nondominant hand) and ΔR2t* in subcortical WM regions. The temporal subcortical WM 
demonstrated the highest correlations with 9HPT. The surface of the cortex was generated by 





Figure 3.11 Results of the correlation analyses between regional tissue damage in the brain and 
PASAT based on all 44 MS patients. All images show the r values of the Pearson’s correlation 
coefficient mapped on the cortical surface. (a,b): correlation between PASAT and ΔR2t* of cortical 
GM. (c,d): correlation between PASAT and ΔR2t* in subcortical WM regions. Subcortical WM 
R2t* showed stronger correlation with PASAT than cortical R2t*. The surface of the cortex was 
generated by FreeSurfer. Deep GM structures, WM and ventricles were excluded. Color bars 





Figure 3.12 Results of the correlation analyses between regional tissue damage in the brain and 
SDMT based on all 44 MS patients. All images show the r values of the Pearson’s correlation 
coefficient mapped on the cortical surface. (a,b): correlation between SDMT and ΔR2t* of cortical 
GM. (c,d): correlation between SDMT and ΔR2t* in subcortical WM regions. Subcortical WM 
R2t* showed stronger correlation with SDMT than cortical R2t*.The surface of the cortex was 
generated by FreeSurfer. Deep GM structures, WM and ventricles were excluded. Color bars 









Figure 3.13 Results of the correlation analyses between brain regional cortical thickness and EDSS 
based on all 44 MS patients. All images show the r values of the Pearson’s correlation coefficient 
mapped on the cortical surface. The thickness of primary motor cortex showed the strongest 
correlation with EDSS. The surface of the cortex was generated by FreeSurfer. Deep GM structures, 
WM and ventricles were excluded. Color bars represent r values. 
 
Figure 3.14 Correlation analysis between R2t* in GM, R2t* in WM and cortical thickness values 
in left and right hemispheres. Our result showed that the left hemisphere and right hemisphere 
R2t* and thickness measurements were highly correlated. 
Table 3.4: Summary of intercept values An resulted from the fitting results for R2t* and 
thickness. The p values for all An are smaller than 0.00001 after multiple comparison. 
ROI Cortical GM Subcortical WM Cortical Thickness 
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bankssts 15.42 19.36 2.91 
caudal anterior cingulate 16.33 19.66 2.79 
caudal middle frontal 14.71 19.01 2.66 
cuneus 17.01 19.22 1.92 
entorhinal 12.41 13.93 3.56 
frontalpole 12.68 17.02 2.98 
fusiform 15.12 18.74 2.73 
inferiorparietal 15.34 18.82 3.13 
inferiortemporal 14.91 18.52 2.70 
insula 12.42 18.21 2.42 
isthmuscingulate 16.24 20.88 2.66 
lateraloccipital 16.39 18.94 2.22 
lateralorbitofrontal 12.29 17.63 2.49 
lingual 16.91 18.80 3.22 
medialorbitofrontal 12.72 18.23 3.23 
middle temporal 14.55 18.66 2.39 
parahippocampal 14.67 16.65 2.72 
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paracentral 15.62 18.71 2.79 
parsopercularis 13.44 19.01 2.50 
parsorbitalis 14.39 18.08 1.62 
parstriangularis 14.75 19.39 2.26 
pericalcarine 16.99 18.59 2.66 
postcentral 15.84 18.40 2.75 
posteriorcingulate 14.86 19.38 2.63 
precentral 15.03 18.87 3.02 
precuneus 15.49 19.04 2.38 
rostralanteriorcingulate 12.76 20.51 2.83 
rostral middle frontal 14.51 19.35 2.42 
superior frontal 13.89 18.39 3.18 
superior parietal 15.42 18.75 2.87 
superior temporal 14.28 18.19 2.92 
supramarginal 14.93 19.12 3.78 
temporalpole 12.25 13.60 2.65 









PASAT SDMT EDSS 
GM WM GM WM GM WM GM WM Thk 
bankssts 0.44 0.37 0.47 0.45 0.29 0.52 0.29 0.45 -0.40 
caudal anterior cingulate 0.16 0.29 0.21 0.31 0.29 0.42 0.24 0.23 0.08 
caudal middle frontal 0.55 0.40 0.56 0.45 0.27 0.41 0.20 0.35 -0.35 
cuneus 0.39 0.33 0.46 0.40 0.44 0.46 0.28 0.31 -0.12 
fusiform 0.23 0.36 0.44 0.53 0.37 0.53 0.31 0.49 -0.42 
inferiorparietal 0.41 0.37 0.43 0.40 0.41 0.53 0.32 0.47 -0.23 
inferiortemporal 0.45 0.47 0.54 0.50 0.44 0.58 0.38 0.46 -0.38 
insula 0.25 0.30 0.45 0.36 0.42 0.40 0.37 0.30 -0.21 
isthmuscingulate 0.41 0.38 0.48 0.45 0.41 0.45 0.37 0.37 -0.30 
lateraloccipital 0.45 0.44 0.43 0.42 0.37 0.49 0.35 0.44 -0.25 
lateralorbitofrontal 0.30 0.39 0.49 0.37 0.33 0.43 0.38 0.34 -0.24 
lingual 0.33 0.36 0.39 0.41 0.37 0.43 0.19 0.27 -0.14 
medialorbitofrontal 0.11 0.12 0.17 0.14 0.08 0.28 -0.03 0.16 0.02 
middle temporal 0.39 0.48 0.45 0.54 0.33 0.47 0.21 0.37 -0.32 
parahippocampal 0.18 0.23 0.22 0.33 0.22 0.38 0.22 0.37 -0.12 
paracentral 0.29 0.35 0.41 0.47 0.30 0.40 0.23 0.35 -0.44 
parsopercularis 0.13 0.27 0.29 0.37 0.32 0.43 0.24 0.32 -0.34 
parsorbitalis 0.11 0.07 0.36 0.24 0.16 0.22 0.18 0.18 -0.05 
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parstriangularis 0.17 0.31 0.37 0.42 0.28 0.51 0.12 0.32 -0.20 
pericalcarine 0.41 0.34 0.49 0.38 0.39 0.39 0.29 0.28 -0.03 
postcentral 0.40 0.33 0.48 0.41 0.40 0.38 0.25 0.30 -0.09 
posteriorcingulate 0.38 0.45 0.40 0.48 0.36 0.41 0.37 0.33 -0.05 
precentral 0.39 0.35 0.47 0.41 0.40 0.41 0.27 0.35 -0.44 
precuneus 0.48 0.38 0.51 0.43 0.44 0.50 0.36 0.45 -0.38 
rostralanteriorcingulate 0.12 0.19 0.12 0.16 0.18 0.33 -0.01 0.14 -0.02 
rostral middle frontal 0.29 0.35 0.41 0.41 0.28 0.42 0.21 0.35 -0.32 
Superior frontal 0.43 0.38 0.47 0.46 0.37 0.51 0.33 0.42 -0.45 
superior parietal 0.39 0.36 0.41 0.39 0.41 0.47 0.34 0.43 -0.18 
superior temporal 0.45 0.37 0.49 0.47 0.34 0.43 0.27 0.36 -0.48 
supramarginal 0.34 0.37 0.41 0.44 0.32 0.49 0.20 0.40 -0.33 
temporalpole 0.16 0.26 0.18 0.30 0.16 0.37 -0.12 0.20 -0.27 
transverse temporal 0.39 0.29 0.50 0.36 0.40 0.39 0.24 0.20 -0.28 
Mean  0.32 0.33 0.40 0.40 0.33 0.43 0.25 0.34 -0.24 
Standard Deviation 0.13 0.09 0.11 0.09 0.09 0.07 0.12 0.09 0.15 
 
 
Table 3.6 List of ROIs in this study  
  ROI in cortical gray matter 




1 cortex-bankssts wm-bankssts 
2 cortex-caudal anterior cingulate wm-caudal anterior cingulate 
3 cortex-caudal middle frontal wm-caudal middle frontal 
4 cortex-cuneus wm-cuneus 
5 cortex-entorhinal wm-entorhinal 
6 cortex-frontalpole wm-frontalpole 
7 cortex-fusiform wm-fusiform 
8 cortex-inferior parietal wm-inferior parietal 
9 cortex-inferior temporal wm-inferior temporal 
10 cortex-insula wm-insula 
11 cortex-isthmus of the cingulate wm-isthmus of cingulate 
12 cortex-lateral occipital wm-lateral occipital 
13 cortex-lateral orbitofrontal wm-lateral orbitofrontal 
14 cortex-lingual wm-lingual 
15 cortex-medial orbitofrontal wm-medial orbitofrontal 
16 cortex-middle temporal wm-middle temporal 
17 cortex-parahippocampal wm-parahippocampal 
18 cortex-paracentral wm-paracentral 
19 cortex-parsopercularis wm-parsopercularis 
20 cortex-parsorbitalis wm-parsorbitalis 
21 cortex-parstriangularis wm-parstriangularis 
22 cortex-pericalcarine wm-pericalcarine 
23 cortex-postcentral wm-postcentral 
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24 cortex-posterior cingulate wm-posterior cingulate 
25 cortex-precentral wm-precentral 
26 cortex-precuneus wm-precuneus 
27 cortex-rostral anterior cingulate wm-rostral anterior cingulate 
28 cortex-rostral middle frontal wm-rostral middle frontal 
29 cortex-superior frontal wm-superior frontal 
30 cortex-superior parietal wm-superior parietal 
31 cortex-superior temporal wm-superior temporal 
32 cortex-supramarginal wm-supramarginal 
33 cortex-temporalpole wm-temporalpole 
34 cortex-transverse temporal wm-transverse temporal 
 
Tissue Damage in MS Lesions based on R2t* 
R2t* values of each imaging voxel in the MS lesions were used to calculate a tissue damage score 
(TDS):  











                                               (3.5) 
where R2t* represents the actual value in a given voxel and R2tc* is a reference value calculated 
based on the distribution of R2t* values in the NAWM of that individual. To calculate this 
reference value, Gaussian function was used to fit the upper half of the R2t* histogram to avoid 
any influence from the “tails” in the histogram. “Normal reference” R2tc* value was defined as the 
center of the Gaussian function after fitting and was different for each subject. Total WM damage 
in the cerebral WM lesions of an individual patient was characterized by the tissue damage load 
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(TDL) calculated by summing individual TDS over all voxels (i) in cerebral MS lesions and 
multiplying by voxel volume V: 
























Chapter 4: Evaluation of Myelin Damage in 
Multiple Sclerosis with SMART MRI 
4.1. Introduction:  
Magnetic resonance imaging (MRI) detects focal WM lesion with high accuracy and has been used 
extensively in MS diagnosis and disease monitoring [12, 13]. However, standard clinical MRI 
lacks specificity to MS pathology and correlates only modestly with MS disability [15, 16]. Many 
studies have been devoted to the development and experimental validation of quantitative methods 
sensitive to myelin damage, primarily by means of multiexponential T2 imaging of water trapped 
between myelin layers, magnetization transfer (MT) and diffusion tensor imaging [reviewed in 
Laule et al [101]]. 
One of these approaches, MT imaging, has been used to estimate myelin damage [28, 29]. In MT 
studies, a model of two cross-exchanging pools has been commonly used: a free (or liquid) pool, 
consisting of highly mobile protons associated with intracellular and extracellular water with long 
T2 (in the range 10 - 100 ms), and a bound pool, consisting of less mobile protons with an ultrashort 
T2 (less than 1ms) associated with macromolecules and membranes in biological tissues. Given 
its ultrashort T2, measuring signals from the bound pool is challenging. However, the exchange 
between the free pool and the bound pool allows indirect measurement of the bound pool using 
MT effects. Loss of myelin leads to decreased concentration of macromolecules and a consequent 
decrease of the bound pool.   
Many MT studies in MS have used the MT ratio (MTR) which measures the relative MRI signal 
intensity decrease in the presence of an off-resonance radiofrequency pulse causing saturation of 
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the longitudinal magnetization of protons bound to macromolecules and consecutive transfer of 
this reduced magnetization to the free water.  MTR depends on MRI pulse sequence parameters 
and is not quantitative. Unlike MTR, quantitative MT (qMT) experiments measure the fraction of 
bound protons versus total protons in both free and bound pools. This fraction has been called the 
Macromolecule Proton Fraction (MPF) [30-33]. Although only protons that can dynamically 
exchange with protons in free water can participate in the MT process, qMT offers improved 
specificity for myelin content and several studies have shown that qMT-defined MPF correlates 
with myelin concentration [34, 35].  However, qMT is limited by long acquisition times, low 
resolution, and high RF energy deposition (especially at magnetic fields 3T and higher).  
Recently, we developed a novel technique, Simultaneous Multi-Angular Relaxometry of Tissue 
(SMART) MRI [62], that addresses these limitations.  The SMART method is based on a gradient 
recalled echo (GRE) MRI and a model of GRE signal that accounts for cross-relaxation effects 
between “free” and “bound” water proton pools. Importantly, no MT pulses are used in SMART 
approach, thus overcoming high RF energy deposition associated with existing qMT approaches 
for evaluation of tissue macromolecular content. From a single protocol this technique can 
generate quantitative MPF images along with naturally co-registered quantitative images of 
longitudinal (R1=1/T1) and transverse (R2*=1/T2*) signal relaxation rate constants, and spin 
density. The SMART technique allows quantitative assessments of central nervous system (CNS) 
simultaneously using several tissue contrasts. 
In the studies reported here, we demonstrate that SMART metrics in brain normal-appearing GM 
and WM detect damage that correlates with neurological impairment, with MS relapsing versus 
progressive clinical subtypes.  The strongest correlations with clinical tests are with the MPF 
metric, which reflects tissue myelin content. 
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4.2. Materials and methods: 
4.2.1 Subjects 
Thirty-three people with MS (pwMS) with relapsing remitting (RRMS, n=11), and progressive 
(n=22) MS clinical courses were enrolled, after providing informed consent.  Progressive subjects 
were selected to be progressing in absence of inflammatory disease activity. SPMS patients with 
superimposed relapses or gadolinium-enhancing lesions within 24 months of entry were excluded. 
All studies were approved by the Washington University Institutional Review Board. 
4.2.2 Clinical testing 
The Expanded Disability Status Scale (EDSS) and the MS Functional Composite (MSFC) along 
with its component 25-foot timed walk (25FTW) assessment of gait, nine-hole peg test (9HPT) 
assessment of upper extremity function, and paced auditory serial addition test (PASAT) 
assessment of cognitive function were performed on the day of the MRI by examiners blinded to 
imaging results. Symbol digit modalities test (SDMT) was also performed. For analyses, the 
25FTW and 9HPT were converted to Z scores according to the following equations (3.1) and (3.2) 
from the MSFC Manual [8]:  
4.2.3 Image Acquisition  
MRI data were collected using a 3T Trio MRI scanner (Siemens, Erlangen, Germany) equipped 
with a 32-channel phased-array head coil. SMART data of voxel size 1x1x1 mm3 were acquired 
using three dimensional multi-gradient-echo sequences with five flip angles α (5°, 10°, 20°, 40°, 
60°) and three gradient echoes (echo times 2.3, 6.2, 10.1ms) for each α. GRAPPA algorithm [102] 
with an acceleration factor of two and 24 auto-calibrating lines in each phase encoding direction 
was used. The scan time for SMART data was 13 minutes 40 seconds (2 minutes 44 seconds per 
flip angle). A phase-based B1 mapping technique accounting for the effects of imperfect RF 
spoiling and magnetization relaxation was implemented [67]. The scan time for B1 mapping was 
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2 minutes. Standard clinical MPRAGE [87] images with voxel size: 1×1×1 mm3 were collected 
for segmentation purposes. FLAIR sequence with voxel size of 1×1×3 mm3 was used for outlining 
WM lesions.  
4.2.4 Image processing and segmentation 
The multi-channel MRI data were combined using a previously published algorithm [51]. The 
combined data were then analyzed voxel-by-voxel using the SMART model, which generalized 
the classical Ernst model by taking into account cross-relaxation effects between “free” and 
“bound” (attached to macromolecules) water pools. The SMART model was described in detail in 
chapter 2. 
Brain GM and WM segmentation was performed on MPRAGE images using FreeSurfer 5.3.0 
(Martinos Center for Biomedical Imaging, MGH/HST, US) with visual inspection of each 
segmented region of interest (ROI) for accuracy.  Sixty-eight cortical GM and 68 corresponding 
subcortical WM ROIs (34 each per hemisphere) were generated (list of ROIs in Supplementary 
Table 4.3). Using FSL 5.0.0 software (Analysis Group, FMRIB, Oxford, UK), MPRAGE images 
were then co-registered with SMART images corresponding to flip angle 20° and TE=2.3 ms (that 
was also used for co-registration of SMART data with other flip angles). This procedure also co-
registered ROIs generated by FreeSurfer to all SMART metrics maps. To minimize partial volume 
effects, CSF masks were generated using FSL based on the SMART images with flip angle 20° 
and TE=2.3 ms. Applying regional and CSF masks, SMART metrics for each ROI in NAGM and 
NAWM were calculated using the median value. Note that we define NAGM and NAWM as 
tissues outside of focal WM lesions.  WM lesion masks were obtained using “lesion-TOADS” tool 
[90] in Medical Image Processing, Analysis and Visualization (MIPAV) software [91] using both 
MPRAGE and FLAIR images co-registered with FSL. 
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4.2.5 Statistical analysis 
SMART metrics in cortical NAGM and subcortical NAWM were examined for correlations with 
EDSS, MSFC (also individually for 25FTW, 9HPT, and PASAT) and SDMT. One progressive 
MS subject was excluded from analysis due to severe image artifacts. Thus, 21 out of 22 
progressive MS subjects were used for subsequent imaging analysis. Statistical program R was 
used for data analysis, with age and gender as covariates. Spearman rank test was used to compute 
rho values. False discovery rate was used to adjust for multiple comparisons. 
 
4.3. Results:  
4.3.1 Examples of IMAGES and Demographic Data of participants  
Examples of axial SMART images corresponding to different SMART metrics, an axial FLAIR 
image and an axial MPRAGE image for a subject with progressive MS are shown in Figure 4.1. 
Red arrows indicate regions of reduced MPF in A, suggesting reduced myelin content. Reduction 
of myelin content is also consistent with reduced signal on R1, R1f, and MPRAGE images, (seen 
as hypointense signals of a focal lesion on R1, R1f and MPRAGE images), and hyperintense signals 





Figure 4.1 Examples of axial SMART metrics images and an axial FLAIR image. MPF [units 
range from 0 (no bound protons) to 1 (no free water)] (A), R1 (1/s) (B), R1f (C), FLAIR (a.u.) (D), 
MPRAGE (a.u.) (1/s) (E) and S0 (a.u.) (F) images were obtained from a thirty four year-old man 
with MS since age 16, now with non-relapsing secondary progressive MS (EDSS 7.5). All images 
demonstrated gray-white matter contrast. One of a focal lesion is pointed out by a red arrow. MPF 
images, as well as R1, R1f, and MPRAGE images, showed hypointense (reduced) signals at sites 
of lesions. Proton density (S0) and FLAIR showed hyperintense signals at sites of lesions. SMART 
images do not exactly match FLAIR due to different slice thicknesses (1 mm for SMART and 3 
mm for FLAIR). a.u. = arbitrary units. Note that the major advantage of SMART is not in detecting 
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lesions but in quantitative assessment of tissue damage both in lesions and in normal appearing 
WM and GM. 
The demographic and clinical information of subjects in the study revealed lower mean EDSS for 
the RRMS group than the progressive group, as expected (Table 4.1).  
Table 4.1 Demographic and clinical information of pwMS in this study. One RRMS and two 
progressive MS subjects were left-handed. The rest were right-handed. 





Number 11 22  







Female/Male 11/0 14/8  
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4.3.2 Correlation Between SMART Metrics and Clinical Assessments 
SMART MPF measurements of NAGM and NAWM of both hemispheres correlated with most 
motor related clinical test scores (Table 4.2). MPF measurements in subcortical NAWM 
demonstrated stronger correlations with clinical test scores than cortical NAGM MPF. In both 
NAWM and NAGM, MPF metrics of the left hemisphere had stronger correlations with clinical 
assessments than metrics of the right hemisphere. This was true even for left hemisphere 
correlations with 9HPT of ipsilateral left hand (Table 4.2, Figure 4.2).    
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Quantitative R1 metric showed significant correlation only with the PASAT in NAGM (r= 0.46, 
p=0.004) and in NAWM (r= 0.38, p=0.025) (Supplementary Table 4.4). R1f correlated only with 
25FTW and 9HPT (r= 0.34, p=0.046; r=0.46, p=0.005, respectively) in the left hemisphere 
(Supplementary Table 4.5).  
 
Table 4.2 MPF in the cortical NAGM and subcortical NAWM correlates with clinical assessments.  
MPF measurements in both NAGM and NAWM correlated most with assessments related to motor 
function, although NAWM MPF had stronger correlations with clinical tests than NAGM MPF. 
The MPF in left hemisphere demonstrated stronger correlation with clinical scores than did MPF 
in the right hemisphere.  For 9HPT, the three left-handed pwMS were removed from analyses.  
Spearman rho and p values were computed in R, with age and gender as covariates. All listed p 
values are after multiple comparison correction using false discovery rate. Statistically significant 
correlations are highlighted in red. 
Since global MPF measurement showed the strongest correlations with clinical tests, MPF was 
selected for region-wise analysis.  Regional MPFs in the left hemisphere showed consistently 
stronger correlations than MPF in the right hemisphere with MSFC, 9HPT, 25FTW and EDSS 
(Figures 4.2 and 4.3). Additionally, in most of the ROIs, MPF in NAWM had stronger correlations 
with clinical test scores than in NAGM.  
rho p rho p rho p rho p
EDSS -0.360 0.009 -0.251 0.070 -0.491 <0.001 -0.314 0.022
25FTW -0.334 0.015 -0.288 0.034 -0.404 0.003 -0.315 0.022
9HPT(Dom) 0.554 <0.001 0.499 <0.001 0.600 <0.001 0.461 0.001
9HPT(NonDom) 0.521 <0.001 0.439 0.002 0.650 <0.001 0.462 0.001
PASAT(2S) 0.067 0.654 0.086 0.570 0.256 0.068 0.223 0.103
PASAT(3S) -0.029 0.820 0.033 0.820 0.149 0.309 0.106 0.473
SDMT 0.136 0.366 0.235 0.095 0.313 0.023 0.249 0.071
MSFC 0.398 0.003 0.359 0.009 0.525 <0.001 0.407 0.003
MPF




Figure 4.2 MPF correlations with 9-hole peg test. MPF in NAGM (top row) and subcortical 
NAWM (bottom row) of the dominant left hemisphere correlated better than the right hemisphere 
with 9-hole peg test results of the non-dominant left hand. Three left-handed subjects were 
removed from the correlation analysis to ensure all remaining subjects have the same dominant 
hemisphere. Interestingly, stronger correlations were noted between the left hand 9-HPT results 
and the ipsilateral MPF in the left hemisphere motor regions than for the same regions in the 
contralateral right hemisphere. More extensive and stronger correlations were noted for NAWM 




Figure 4.3 Correlations of MPF with MSFC scores. MPF in subcortical NAWM (bottom row) 
correlated better than subcortical NAGM (top row) with MSFC.  All pwMS were included in this 
correlation analysis. No clear differences between hemispheres were noted. Color bar: scale of 
Spearman rho values.   
 
MPF in both left and right hemispheres of NAGM and NAWM differentiated relapsing-remitting 
from non-relapsing progressive cohorts at the group level, although there was considerable overlap 
of individual subjects between the two clinical subgroups (Fig. 4.4). In particular, MPF of 




4.3.3 Distinguishing Progressive MS from RRMS by SMART Metrics 
 
Figure 4.4 Group comparisons based on MPF measurement in cortical NAGM of left (A) and right 
(B) hemispheres, and left (C) and right (D) hemispheres of subcortical NAWM revealed higher 
MPF in the RRMS than progressive MS group. In both GM and WM, MPF measurements of the 
left hemisphere differentiated the two MS subtypes better than MPF of right hemisphere. Boxes 
represent the interquartile ranges; the horizontal lines within the boxes are median values, points 
are median values of individual subjects.  p values were determined after adjusting for multiple 




Figure 4.5 Regional MPF of the left hemisphere is higher in RRMS than progressive MS cohorts 
in cortical NAGM and subcortical NAWM.  Median values of MPF measurement of each 
cortical/subcortical ROI in the left hemisphere for each clinical subtype are plotted. Error bars are 
the standard error of MPF measurement.  MPF in NAWM ROIs were significantly higher than 




In agreement with higher concentration of myelin in WM as compared to GM, region-wise analysis 
showed that MPF measurements in subcortical NAWM were universally higher than in cortical 
NAGM, as shown for the left hemisphere in Figure 4.5. Similar results were found in the right 
hemisphere. (Supplementary Figure 4.6). The RRMS cohort had higher MPF measurements than 




Imaging biomarkers of tissue damage and repair are needed to facilitate the search for effective 
treatments for MS at different stages. Although quantitative MRI [MT, MR relaxometry (T1, T2, 
T2*) and diffusion] have been widely used to assess CNS tissue damage in MS, they have not 
gained traction in clinical practice, prompting searches for novel, more pathologically specific and 
efficient approaches. In this study, we applied the newly developed SMART MRI technique for in 
vivo evaluation of myelin damage in brains of people with MS. The SMART technique generates 
naturally co-registered multi-contrast quantitative data for several MR parameters (SMART 
metrics).  Importantly, SMART MRI metrics allow assessment of the exchange between “free” 
and “bound” water compartments by measuring MPF, thus allowing estimation of brain tissue 
macromolecular content similar to quantitative MT. Compared with standard T1W and T2W 
imaging and MTR, SMART MRI metrics provide quantitative information on brain tissue damage 
not only in MS lesions but also in normal-appearing WM and GM, which is not readily visible on 
standard clinical MRI. Notably, an advantage of the SMART technique is that it does not apply 
either MT or 180° radiofrequency pulses, which means it avoids high energy deposition on patients, 
making it safe at high field MRI.   
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The multi-contrast battery of naturally co-registered SMART images/metrics includes 
measurements of MPF, cross-relaxation-affected T1 and spin density of free water. In this paper 
we presented results of high resolution (1x1x1 mm3) SMART protocol that required about 16 
minutes of MRI time. This time can be significantly reduced by selecting different image 
resolutions. For example, for 1x1x2 mm3 image (often used in clinical settings) the protocol would 
require less than 9 minutes, still producing the whole battery of SMART images.  
4.4.1 SMART Metrics Showed Strong Correlation with Patients’ Clinical 
Scores 
In this study we asked if the novel imaging method, SMART MRI, could detect and quantify brain 
tissue damage, in particular myelin damage, in pwMS and whether this might correlate with 
clinical test results or clinical subtypes (RRMS versus progressive). To address these questions, 
brain tissue was segmented into normal-appearing tissue (NAGM and subcortical NAWM) and 
focal lesions visible on standard clinical images and assessed by SMART MRI. The left and the 
right hemispheres were analyzed separately to explore differences in the two sides, yielding 
interesting stronger associations of the dominant hemisphere with both contralateral and ipsilateral 
motor functions.  
MPF derived using SMART MRI of the brain showed significant correlations with motor-related 
clinical test scores at a global and regional level.  MPF in NAWM was higher than in NAGM, 
consistent with the notion that protons bound to macromolecules are more abundant in highly 
myelinated regions.  R1 and R1f showed modest but significant correlation with PASAT and motor-
related tests, respectively. We found lower MPF and R1 (1/T1) signals in MS lesions than in normal 
appearing tissues, in agreement with previous reports of hypointense MPF [30, 106] and T1 [107] 
signals in demyelinated and dysmyelinated CNS tissue. The values of MPF and R1 we observed 
in this study were in general agreement with published studies [108, 109].  
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4.4.2 MPF Distinguishes Progressive MS from RRMS 
In clinical practice, progressive MS subtypes (secondary progressive (SP) MS and primary 
progressive (PP) MS) present a major treatment challenge, compared with the RRMS subtype. 
Few disease-modifying therapies have been effective for progressive MS. The reason for this may 
be related to the less inflammatory pathophysiology of progressive MS [7, 110] that is not detected 
well using conventional imaging techniques. Suitable imaging surrogates of progression are 
lacking as outcome measures for trials and thus, a new noninvasive imaging technique that can 
sensitively and reproducibly measure CNS tissue changes due to progressive MS is very much 
needed [111]. In this study, progressive MS subjects were specifically selected to be progressing 
in absence of inflammatory disease activity (superimposed relapses or gadolinium-enhancing 
lesions) within the prior 2 or more years. This non-inflammatory progressive MS cohort was 
distinguishable from the RRMS group using SMART metrics.  
Previous studies have shown MPF measurements to be highly correlated with myelin content [34, 
35].  One clear finding from this our study was that MPF in NAGM was universally lower than in 
NAWM, which likely reflects the lower myelin content of GM than WM. MPF measurement 
differentiated the RRMS group from the progressive MS group, with RRMS consistently showing 
higher MPF values in almost all ROIs.  For both global (entire cerebral cortical NAGM and 
subcortical NAWM) and regional-wise measurements, MPF in NAWM distinguished the RRMS 
from the progressive MS cohort best among the SMART metrics. This result is in agreement with 
published pathology studies showing greater myelin loss in progressive than RRMS patients [110, 
112] and suggests that SMART MPF could be useful as an outcome measure in trials of 
remyelinating agents.  
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Improved and quantitative imaging biomarkers are greatly needed in the MS field [111].  
Specifically needed are methods to readily assess cortical gray matter damage, to measure 
repair/remyelination in clinical trials of putative reparative treatments, and to detect progression 
unrelated to overt inflammation as an outcome measure in trials of disease-modifying therapies 
for progressive disease.  Our results using the SMART MRI metrics suggest it to be a safe, rapid 
and accurate imaging technique that holds promise as a needed biomarker to detect unseen cortical 
(and WM) damage. Moreover, it holds promise to provide an estimation of myelin content that 
could be useful for trials of remyelinating therapies.   SMART metrics distinguished RRMS from 
progressive patients at the group level, and longitudinal studies with larger cohorts are underway 
to evaluate whether the SMART metrics might serve as a surrogate of MS disease progression.  
The battery of SMART images allows simultaneous assessment of tissue damage from different 
perspectives.  In this paper we assessed tissue damage using SMART metrics independently, 
finding that some metrics correlate better than others with different clinical tests and MS subtypes. 
To take full advantage of the whole battery of SMART metrics, our future work will encompass 
building models that would include all SMART metrics for better and more specific assessment 
of tissue pathology. 
4.5. Conclusions 
SMART MPF showed significant correlations with clinical motor assessments in pwMS, and 
distinguished RRMS from progressive MS subtypes at a group level. In particular, SMART allows 
evaluation of tissue macromolecular content (MPF metric) with higher resolution and lower RF 
energy deposition compared to existing qMT approaches, thus offering an improved method of 
assessing myelin integrity in MS. These findings indicate the high potential of SMART MRI 
technique for MS diagnostics and clinical monitoring and as an outcome measure in clinical trials. 
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4.6 Supplementary Information: 
Table 4.3. List of Regions of Interest (ROIs)  
  ROI in cortical gray matter 
ROI in subcortical white 
matter 
1 
cortex-banks of the superior 
temporal sulcus 
WM-banks of the superior 
temporal sulcus 
2 cortex-caudal anterior cingulate WM-caudal anterior cingulate 
3 cortex-caudal middle frontal WM-caudal middle frontal 
4 cortex-cuneus WM-cuneus 
5 cortex-entorhinal WM-entorhinal 
6 cortex-frontal pole WM-frontal pole 
7 cortex-fusiform WM-fusiform 
8 cortex-inferior parietal WM-inferior parietal 
9 cortex-inferior temporal WM-inferior temporal 
10 cortex-insula WM-insula 
11 cortex-isthmus of the cingulate WM-isthmus of cingulate 
12 cortex-lateral occipital WM-lateral occipital 
13 cortex-lateral orbitofrontal WM-lateral orbitofrontal 
14 cortex-lingual WM-lingual 
15 cortex-medial orbitofrontal WM-medial orbitofrontal 
16 cortex-middle temporal WM-middle temporal 
17 cortex-parahippocampal WM-parahippocampal 
18 cortex-paracentral WM-paracentral 
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19 cortex-parsopercularis WM-parsopercularis 
20 cortex-parsorbitalis WM-parsorbitalis 
21 cortex-parstriangularis WM-parstriangularis 
22 cortex-pericalcarine WM-pericalcarine 
23 cortex-postcentral WM-postcentral 
24 cortex-posterior cingulate WM-posterior cingulate 
25 cortex-precentral WM-precentral 
26 cortex-precuneus WM-precuneus 
27 cortex-rostral anterior cingulate WM-rostral anterior cingulate 
28 cortex-rostral middle frontal WM-rostral middle frontal 
29 cortex-superior frontal WM-superior frontal 
30 cortex-superior parietal WM-superior parietal 
31 cortex-superior temporal WM-superior temporal 
32 cortex-supramarginal WM-supramarginal 
33 cortex-temporal pole WM-temporal pole 
34 cortex-transverse temporal WM-transverse temporal 
35 cortex-cerebellum WM-cerebellum 
 
Table 4.4 Global R1 measurements in cortical GM and subcortical WM showed few 
correlations with clinical assessments. The only significant correlations for R1 measurements 
were with the two second PASAT, a test of cognitive function test. For 9HPT, three left-handed 
subjects were removed to ensure all test subjects were right handed. Spearman rho and p values 
were computed in R, with age and gender as covariates. All listed p values are after multiple 
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comparison correction using false discovery rate. Statistically significant correlations are 
highlighted in red. 
 
Table 4.5.  Global R1f measurements in cortical NAGM and subcortical NAWM of left and 
right hemispheres showed significant correlations of left hemisphere NAGM with 25FTW 
and 9HPT.  NAWM of the left hemisphere correlated modestly with non-dominant hand 9HPT 
test results. For 9HPT, three left-handed subjects were removed to ensure all remaining subjects 
have the same dominant hemisphere. Spearman rho and p values were computed in R, with age 
and gender as covariates. All listed p values are after multiple comparison correction using false 
discovery rate. Statistically significant correlations are highlighted in red.  
rho p rho p rho p rho p
EDSS -0.095 0.667 -0.146 0.475 -0.132 0.514 -0.089 0.673
25FTW 0.131 0.514 0.049 0.765 -0.044 0.765 -0.049 0.765
9HPT(Dom) 0.048 0.765 0.176 0.419 0.101 0.665 0.227 0.281
9HPT(NonDom) -0.027 0.844 0.043 0.765 0.044 0.765 0.087 0.681
PASAT(2S) 0.461 0.004 0.411 0.013 0.337 0.054 0.375 0.025
PASAT(3S) 0.267 0.157 0.210 0.281 0.276 0.144 0.327 0.054
SDMT 0.045 0.765 0.163 0.419 0.156 0.419 0.243 0.196
MSFC 0.113 0.601 0.214 0.281 0.158 0.419 0.190 0.354
R1




Figure 4.6. Regional MPF of the right hemisphere is higher in RRMS than progressive MS cohorts 
in cortical NAGM and subcortical NAWM.  Median values of MPF measurement of each 
cortical/subcortical ROI in the right hemisphere for each clinical subtype are plotted. Error bars 
are the standard error of MPF measurement.  MPF in NAWM ROIs were significantly higher than 
MPF in NAGM, consistent with the greater myelin content of WM. 
rho p rho p rho p rho p
EDSS 0.265 0.122 0.176 0.246 0.179 0.246 0.104 0.476
25FTW 0.344 0.046 0.290 0.122 0.188 0.246 0.161 0.288
9HPT(Dom) -0.462 0.005 -0.263 0.144 -0.293 0.122 -0.152 0.321
9HPT(NonDom) -0.461 0.005 -0.287 0.122 -0.369 0.046 -0.217 0.211
PASAT(2S) 0.211 0.200 0.201 0.211 0.224 0.178 0.240 0.155
PASAT(3S) 0.179 0.246 0.176 0.246 0.222 0.178 0.261 0.122
SDMT -0.048 0.735 0.065 0.627 0.060 0.643 0.127 0.377
MSFC -0.265 0.122 -0.148 0.321 -0.155 0.304 -0.077 0.606
R1 f
NAGM(left hemisphere) NAGM(right hemisphere) NAWM(left hemisphere) NAWM(right hemisphere)
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Chapter 5: Future Plan 
 
In this study, two novel GRE based MRI techniques, GEPCI and SMART, have been used to 
quantitatively study MS tissue damage. For the GEPCI technique, our results show moderate to 
strong correlations between cervical spinal cord size and GM R2t* values and thickness of several 
brain cortical regions. This finding supports the well-known idea that MS is a global CNS disease, 
affecting both spinal cord and brain. Cervical cord CSA correlated better with physical impairment 
status, compared with R2t* and thickness of brain cortex. Spinal cord size, thickness and ΔR2t* 
values of the cortex all differentiated MS patients from healthy controls. Additionally, upper 
cervical cord size and GM thickness demonstrated significant differences between MS clinical 
subtypes. 
For the SMART technique, our results showed that MPF can distinguish non-relapsing progressive 
MS from RRMS and to examine correlations with clinical assessments. Without applying either 
MT or 180° radiofrequency pulses, SMART MRI generates high resolution quantitative images 
with various contrasts, and is safe for high-field MRI, making it a useful outcome measure in 
clinical trials. 
Of course, there are much more in the GEPCI and SMART techniques that one can carry on 
investigating.  
1) In the future, the GEPCI and SMART techniques should be applied to a large cohort of MS 
patients at different disease stages. This will give us stronger statistical power to support our 
preliminary results.  
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2) As a CNS disease, MS can affect brain, cerebellum, brain stem, spinal cord. Currently, the 
GEPCI and SMART techniques focus on tissue damage in brain. Future work should include other 
regions of the CNS. To achieve this goal, the GEPCI and SMART pulse sequence would have to 
be modified to overcome technical issues such motion and magnetic field inhomogeneity. 
3) In chapter 3, our results showed that the spinal cord size had significant correlation with MS 
patients’ clinical assessments. Other volumetric measurements such as brain volume should be 
included in future data analysis. 
3) In both GEPCI and SMART projects, the central vein sign in active MS lesions has not been 
explored. In recent years, many studies have showed that the presence of central vein could 
distinguish MS from other neurological diseases [113]. Future work will explore the possibility to 
detect central vein in MS lesions using our GEPCI and SMART images. 
4) Myelin damage is the hallmark of MS pathology. The myelin structure can be divided into 
several compartments. Each of them has unique MR signal decay properties. Therefore, it is 
important to incorporate the multi-compartments structures into the GEPCI and SMART models.  
5) In this study, the severity of tissue damage in MS lesions has been quantified using the GEPCI 
and SMART techniques. However, other factors such as the locations of lesions play an important 
role in explaining patients’ clinical symptoms and signs. Future work should consider these 
important factors while evaluating tissue damage in MS lesions.   
6) Histopathological studies should be performed in the future to further validate the candidacies 
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